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Cells can mediate intercellular communication by the secretion and uptake of 
microvesicles, nano-sized membranous particles that carry signaling molecules, antigens, 
lipids, mRNA and miRNA between cells. The biological function of these vesicles is 
dependent upon their composition and cellular origin which is regulated by mechanisms 
that are not well understood. Based on their molecular content, microvesicles may play a 
role in immune regulation, cancer progression, the spread of infectious agents and 
numerous other important normal and pathogenic processes. The proteomic content of 
microvesicles from diverse sources has been intensely studied. In contrast, little is known 
about their glycomic content. The glycosylation pattern of a protein or lipid plays a key 
role in determining its functional properties in several ways.  Glycans can determine the 
trafficking of a protein to particular regions of the cell as well as the protein’s half life. In 
addition, the glycan-dervied oligomerization of glycolipids and glycoproteins is a known 
mechanism for the activation of receptors and recognition of ligands on the surface of the 
cell. Glycomic analysis may thus provide valuable insights into microvesicle function.  
I utilized lectin microarray technology to compare the glycosylation patterns of 
microvesicles derived from a variety of biological sources. When compared to cellular 
membranes, microvesicles were enriched in high mannose, polylactosamine, α2-6 sialic 
acid, and complex N-linked glycans but exclude terminal blood group A and B antigens.  
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The polylactosamine signature in microvesicles from different cell lines derives from 
distinct glycoprotein cohorts. After treatment of Sk-Mel-5 cells with lactose to inhibit 
lectin-glycan interactions, secretion of microvesicle resident proteins was severely 
reduced. Taken together, this work provides evidence for a role of glycosylation in 
microvesicle-directed protein sorting. 
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Chapter 1:  Introduction 
1.1 OVERVIEW 
Microvesicles are a diverse group of cellular messengers, influencing their 
environments in critical ways that scientists have only just begun to appreciate [1]. 
Despite the fact that glycans play a fundamental role in many aspects of cellular biology 
and communication, the glycosylation of these particles is an overlooked and 
underrepresented aspect of microvesicle research. The focus of my dissertation is to 
comprehensively examine and compare the carbohydrate profiles of extracellular 
microvesicles and investigate whether glycosylation influences microvesicle content. To 
this end, I have isolated and characterized secreted vesicles from a diverse panel of 
biological sources and utilized lectin microarray technology as a tool for comparative 
analysis of microvesicle glycosylation. Microvesicles from a diverse panel displayed a 
conserved carbohydrate signature suggesting the existence of an active microvesicle-
directed sorting mechanism. The final chapter describes steps taken to investigate 
whether glycan-lectin interactions are involved in microvesicle protein sorting.  
This introductory chapter gives a brief background on the biogenesis of 
microvesicles and discusses some of the confusion in the literature. In addition, some 
examples of their biological and clinical importance are provided with an emphasis on 
how cellular origin and content can vastly influence function. Due to their biogenesis, 
microvesicle membranes are a derivative of the plasma membrane [2]. As such, they 
contain proteomic, lipidomic and glycomic features that are relative to cellular 
membranes [3-5]. Therefore, the typical glycans of mammalian cellular membranes are 
introduced, with examples of some of the important roles ascribed to glycans. In addition, 
central aspects of glycobiology are discussed, such as the tools used to study glycans and 
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the challenges that arise from their inherent properties. Finally, I will explain the concept 
of lectin microarrays and why this particular technology is well suited for comparative 
analysis of multiple samples. 
 
1.2 MICROVESICLES 
It is now widely accepted that cells can mediate intercellular communication by 
the release of microvesicles that can shuttle biologically active molecules to recipient 
cells. Microvesicles are composed of cytosolic content enclosed by a phospholipid 
bilayer with the same outside orientation as the cell membrane. They are essentially small 
cellular packages, exporting an assortment of soluble and membrane-bound proteins, 
lipids, small molecules and nucleic acids to the extracellular space [1, 6-8]. First 
described in 1963 as “dust” produced by platelets, secreted vesicles were considered at 
that time to be inert cellular debris [8]. Research from the past three decades strongly 
supports the currently held view that vesicle secretion is a biologically important cellular 
process conserved from eukaryotes to humans. Since first identified, they have been 
isolated and studied from the in vitro cultures of numerous species and cell types as well 
as from physiological fluids such as urine, blood, saliva, seminal fluid, breast milk, and 
tumor effusions [4, 8, 9]. Through transport in biological fluids they can potentially 
communicate with other cells at considerable distances in a manner analogous to the 
endocrine system.  
 
Nomenclature 
Microvesicles have been the focus of intense research due to their promising 
pontential for clinical applications, implications in various pathogenesis processes and 
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possible role in a number of intercellular signaling events [10-14]. Nevertheless, the 
scientific community has not reached a consensus on the terminology used for this 
heterogeneous group of organelles. Researchers tend to classify these particles based on 
several different categories: 1) their phenotypic characteristics, such as size and content, 
2) their cellular origin, 3) their biological impact and 4) their biogenesis or cellular exit 
pathway. For example, scientists have used the terms microvesicles and nanovesicles to 
define two broad categories of vesicles based on size [15]. With regard to cellular origin, 
content or biological impact, it can be said that these are heavily intertwined, with 
cellular origin dictating vesicle content which in turn has an effect on its biological role. 
Thus, the terms oncosomes, prostasomes, melanosomes, tolerosomes, prominosomes and 
dexosomes are just some of the many descriptive names given to secreted vesicles [16]. 
The popular term, microparticles, typically refers to procoagulant vesicles found in the 
bloodstream and may originate from platelets, granulocytes, monocytes, endothelial cells, 
smooth muscle cells, and tumor cells [17].  
Extracellular vesicles are categorized by one of three known biogenesis pathways, 
however, the possible existence of other mechanisms cannot be ruled out. As the name 
implies, apoptotic blebs/bodies/vesicles are the result of systematic cellular breakdown 
from apoptosis. To make matters more confusing, the term apoptosome refers to a large 
protein structure formed at the onset of apoptosis and despite similarities with the way in 
which other vesicles are named, is not used to describe secreted apoptotic vesicles [18]. 
The size distribution of apoptotic vesicles has not been systematically identified but 
generally these particles are heterogeneous in size and can be greater than 1 µm in 
diameter. Apoptotic vesicles are known to display phosphatidyl serine (PS) on the outer 
leaflet of their membranes and contain cellular material including genomic DNA and 
intact organelles [19]. The process of clearing these vesicles from the body is performed 
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by macrophages and other phagocytes [20]. In the absence of clearance, such as in 
impaired immunity or in vitro cell cultures, apoptotic vesicles may interact with and 
influence other cells.  
A second biogenesis mechanism involves the outward budding and subsequent 
expulsion of vesicles directly from the cellular membrane surface. As in the previous 
category, many terms have been coined to describe membrane shed vesicles including 
shedding microvesicles, ectosomes, membrane microvesicles and microparticles [8, 21]. 
These vesicles are sometimes referred to as ectosomes in the literature. The term 
ectosome is used in reference to the process of ectocytosis which is the shedding of 
proteins from the ectodomain of cells. Ectosomes are heterogeneous in size ranging from 
100 nm to several microns, but smaller vesicles that are 50-80 nm in size have also been 
observed [22]. They are commonly characterized by the presence of lipid-raft domains 
and exposure of PS on the outer surface [23]. However, whether these diverse vesicles all 
share the same properties is unknown. Budding of vesicles from the cell membrane has 
been observed in numerous cell types as either a constitutive process or by activation of 




           
Figure 1.1: Schematic representation of microvesicles that are shed from the outward 
budding of the plasma membrane (ectosomes). They contain cytosolic 
material and are enveloped by a phospholipid bilayer. 
Exosomes are vesicles of endosomal origin. After endoctyosis, cargo is sorted 
either to the lysosome or to late endosomal compartments. Smaller vesicles are then 
formed from the inward budding of the limiting membranes of multivesicular bodies 
(MVB) and release happens upon fusion of the MVB with the plasma membrane. These 
vesicles are reportedly more homogeneous in size and appearance, with a size range of 
about 30 to 100 nm and a cup-shaped morphology seen by electron microscopy [1, 15]. 
Of the three broad categories of extracellular vesicles, exosomes have been the most 
widely studied in terms of their proteomic and nucleic acid content. Consequently, 
proteomic studies have identified several commonly incorporated exosomal proteins 
including members of the tetraspanins and heat shock proteins. These proteins, 
considered exosomal markers, are often used to identify exosomes and differentiate them 
from shedding vesicles [1, 4].    
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 One of the main problems in the scientific literature is that the terms used to 
describe extracellular vesicles can often have several opposing definitions. For example, 
the word microvesicle is at times used to encompass all secreted vesicles including 
exosomes and apoptotic vesicles [24]. On the other hand, some researchers use this term 
to refer exclusively to the larger shedding vesicles [8]. Similarly, many articles claim to 
be studying exosomes based solely on reports of size, density or the presence of one or 
two “exosomal markers” with no other proof that the vesicles are of endosomal origin. 
The problem with this is that when comparing the numerous exosome proteomic studies, 
there is not one single marker that is consistently present in all of them [1]. The question 
remains whether this is due to the lack of a true marker, or whether all of these studies 
were indeed done on bona fide exosomes. As mentioned previously, vesicles with a size 
and density similar to exosomes have been reported to arise from the direct budding of 
the cell membrane of neural progenitor and epithelial cells. These vesicles were obtained 
as a heterogeneous mixture with exosomes but there was a clear distinction in their 
protein content and they did not contain the marker CD63 whereas the exosomes did [25, 
26]. On the other hand, vesicles have also been observed to bud directly from the 
tetraspanin-enriched domains of T-cell plasma membranes [27]. The idea that two 
separate vesicle populations exists containing larger membrane shed ectosomes and 
smaller endosomal exosomes positive for CD63 came from studies done on platelets [28]. 
However, it is possible that these absolute distinctions cannot be universally made across 
all cell types. It is clear that we need to have a better understanding of these extremely 
diverse extracellular messengers.  
For the purposes of this manuscript, I will use the term microvesicles to refer to 
the secreted vesicles of endosomal and plasma membrane origin from all biological 
sources with the exclusion of apoptotic vesicles. I will distinguish between them when 
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referring to literature that clearly makes the distinction. The microvesicles obtained in the 
work described in this dissertation are 40 – 100 nm in size and contain the exosomal 
markers, CD63 and CD81. However, because the biogenesis of these microvesicles was 
not defined, I will not refer to them as exosomes.  
 
 
Figure 1.2: Schematic representation of the biogenesis of exosomes. Endocytic vesicles 
are targeted to the early endosome where proteins are either trafficked back 
to the plasma membrane or sent to the late endosome. In the late endosome, 
cargo is sorted to the lysosome for degradation or to multivesicular bodies. 
Exosomes are formed from the inward budding of limiting membranes. The 
MVB fuses with the cell membrane and releases exosomes into the 




Biological and clinical significance 
Microvesicles have been implicated in a myriad of normal and pathogenic cellular 
processes. Although they are known to share many similar characteristics, the diversity of 
their biological impact stems from the unique properties inherited from parent cells as 
well as the properties of the recipient cells. Several studies have shown that microvesicles 
can interact with cells in many different ways including fusion and subsequent release of 
their content [29]. Because of their many components, including membrane bound 
receptors, soluble ligands, mRNA and microRNA, this can lead to pleiotropic 
consequences for the recipient cell (Figure 1.3). Those consequences vary from cell to 
cell and are dependent on many factors, the arguably most important of these is the 
molecular content of the vesicle.  
A simple explanation of the role of microvesicles is that they advance the agenda 
of the parent cell. This can be seen in numerous examples. For instance, platelet 
microvesicles have procoagulant properties [30, 31] whereas dendritic cell vesicles 
stimulate the immune system by activating T-cells and microglia [32, 33]. The latter has 
led to enthusiasm for the potential to utilize immuno-stimulatory microvesicles as anti-
cancer agents. Anti-tumor responses were upregulated in mouse models upon treatment 
with microvesicles from dendritic cells pulsed with tumor antigens as well as tumor-cell 
derived microvesicles [12, 14]. In addition, it is believed that microvesicle secretion is 
exacerbated with the onset of cancer given that greater quantities are found in the fluids 
of cancer patients [8, 34]. This increase has also been associated with conditions such as 
atherosclerosis [31, 35], diabetes [36], preeclampsia [37], and other inflammatory 
disorders [23]. Differences in proteomic and nucleic acid content can be detected when 
comparing normal and diseased vesicles. As a result, the use of circulating microvesicles 
 9 
as biomarkers for the non-invasive detection of various diseases is under investigation 
[38-40]. Thus, there are many promising therapeutic uses currently being explored. 
In contrast to their proposed stimulatory role, microvesicles can also be immuno-
suppressive in their function, promoting immune tolerance to cancerous tumors, to food 
antigens in the gut [41], during pregnancy [42-45] and breast feeding [46]. One of the 
ways in which both cancer cell and placenta microvesicles are thought to achieve this is 
by presentation of the Fas ligand on the vesicle surface which leads to the activation of T-
cell apoptosis [47]. In addition to evasion of the immune system, tumor derived 
microvesicles are implicated in disease progression by several other methods. These 
include epigenetic transformation of neighboring cells [19, 48], promotion of 
angiogenesis [49], and the creation of a pre-metastatic niche [50]. The propensity of 
microvesicles to expose recipient cells to regulatory and signaling molecules is a 
powerful tool used for the propagation of cancer and other diseases. The above examples 
are by no means comprehensive, as microvesicles have been described in countless other 




Figure 1.3: The interaction of microvesicles with acceptor cells can have pleiotropic 
consequences.  (A) Exposed ligands on the microvesicle surface leads to 
receptor activation of the recipient cell and activation of cell signaling. (B) 
Fusion of the microvesicle with the cell leads to incorporation of membrane 
bound proteins. This can lead to cellular transformation as seen in the 
transfer of the mutant, hyper-active form of EGFR from cancer cell 
microvesicles to normal cells. (C) Uptake of microvesicles also leads to 
transfer of cytosolic material such as soluble proteins, small molecules and 
RNA. The transfer of miRNA can lead to various epigenetic reprogramming 




The diversity of proteins and lipids found in organisms can be amplified by the 
addition of carbohydrate moieties which can alter both structure and function. This 
process of glycosylation is conserved across all domains of life and is the most abundant 
post-translational modification found in nature [51]. Glycans are involved in countless 
important biological processes including protein maturation and stability, cellular 
adhesion, receptor activation, immunity and host-pathogen recognition [52]. In fact most 
extracellular events are the product of some form of glycan interaction. As a result, all 
cells from bacterial to mammalian are densely covered in carbohydrates. Given their 
importance, it seems odd that glycobiology, the study of the biological role of 
carbohydrates, is an understudied field [53].  
 
The glycosylation of mammalian cell membranes 
Glycans, from single monosaccharides to highly complex oligosaccharide 
structures can exist in free form or covalently attached by a glycosidic bond to lipids and 
proteins. The most common and diverse type of glycolipids found in animals are 
glycosphingolipids, in which the glycan is attached to the hydroxyl group of a ceramide. 
As seen in the myelin sheath of neurons, they can account for a substantial portion of the 
cell membrane content. They are typically found in clusters within lipid raft domains and 
are involved in the activation of various cell signaling events [54]. A second group of 
glycolipids are the glycosylphosphatidylinositol (GPI) anchors, composed of 
phosphatidylinositol and ethanolamine linked by a glycan bridge and attached to the 
carboxy terminus of proteins via the ethanolamine [55]. GPI anchors are diverse because 
the properties of both the lipid and glycan can vary and they may be attached to one of 
many different proteins or no protein at all. Like glycosphingolipids, GPI anchored 
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proteins associate with lipid rafts and are involved in cell signaling [56]. In addition, GPI 
anchored proteins are known to be enriched in microvesicles [57]. 
The two major classes of membrane glycoproteins are formed from the glycosidic 
linkage of oligosaccharides to either the nitrogen of asparagines (N-linked glycans) or the 
hydroxyl oxygen of serines and threonines (O-linked glycans) on proteins. Processing of 
N-linked glycans occurs in the lumen of the ER and golgi by the sequential action of 
numerous glycosidases and glycosyltransferases. All N-linked glycans are attached to the 
protein via a conserved pentasaccharide core structure composed of Man3GlcNAc2 linked 
to asparagine. The fully formed N-linked glycans are classified into one of three 
categories: high mannose (oligomannose), complex and hybrid (Figure 1.4). These 
diverse glycans can be rather complex, with highly branched tri- and tetra-antennary 
structures composed mostly of mannose (Man), galactose (Gal) and N-acetyl-D-
glucosamine (GlcNAc) and typically capped with N-acetyl-D-galactosamine (GalNAc), 
fucose (Fuc) or sialic acid (NeuAc) [58].     
One of the most well known roles of N-glycosylation is to aid in the maturation 
and quality control of proteins. However, the abundance of this modification on 
membrane bound and secreted glycoproteins implies an essential role in numerous other 
extracellular processes. Studies based on N-linked glycosylation mutants have shown that 
the absence or aberration of this modification can have profound effects on cellular 
development and can even be lethal in embryonic mice [59]. These adverse effects are 
due to changes in one or several features of normal proteins leading to changes in protein 
function. An example of this is highlighted in studies of the neurotransmitter transporter, 
GAT1, where different glycosylation mutants led to either decreased protein stability, an 
arrest in cell membrane trafficking or a decreased affinity for the substrate. In all cases, 
changing the N-linked glycosylation of GAT1 essentially inhibited its function [60].  
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Figure 1.4: The three categories of N-linked glycans are complex, high mannose and 
hybrid. Examples of each are shown. 
 
The most abundant type of O-glycosylation is initiated by the addition of GalNAc 
linked α to serines or threonines. Proteins containing high amounts of this type of 
modification (called the Tn antigen) and extensions thereof are known as mucins and 
mucin-like glycoproteins. Extension of the Tn antigen occurs by the addition of Gal, 
GlcNAc, Fuc and NeuAc to form linear or highly branched polymers. In contrast to N-
glycoproteins, which all have the same core, mucin glycans can contain one of eight 
different core structures, the most common being the core 1 or T antigen. Mucins are 
heavily glycosylated secreted and cell surface proteins. As the name implies, they are 
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responsible for the protective and hydrating mucous secretions of epithelial cells [61]. O-
GalNac glycans are similar to N-linked glycans in that they can be important for protein 
stability, trafficking and function [62]. Additionally, O-linked glycans are involved in 
immunity, tissue development, cell adhesion and other cellular interactions. Studies of 
mice deficient in the transferase gene responsible for the addition of the core 1 had 
defective angiogenesis and died by embryonic day 14 [63]. This demonstrates the 
importance of O-linked glycosylation for normal development. 
Examples of the different types of glycan modifications described above are 






Figure 1.5: Examples of common glycan modifications found on plasma membrane 
proteins and lipids.  
 
The complexity of glycans leads to challenges in the field  
In order to gain a greater understanding of the role of glycosylation on biological 
processes, researchers must investigate how the diverse properties of glycans can 
influence protein function. The field of glycobiology is faced with several challenges due 
to the inherent properties of carbohydrates. In a glycosidic bond, a monosaccharide can 
form either an α or β linkage to one of several hydroxyl groups on another 
monosaccharide. In addition, monosaccharides can form more than two glycosidic bonds 
to form branched polymeric structures with multiple possible combinations of glycosidic 
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linkages [64]. This is in contrast to the linear polymers formed from the single possible 
linkage of amino acids and is one of the reasons for the greater complexity and diversity 
of carbohydrate structures.  This structural diversity is what allows carbohydrates to be 
the determinants of intercellular recognition and communication. 
Knowledge of the sequence, glycosidic linkage and overall structure of a 
carbohydrate, requires the application of several analytical tools. Obtaining the 
monosaccharide composition of a glycan through means such as mass spectrometry, high 
performance liquid chromatography (HPLC) or gas chromatography (GC) does not 
provide information of the anomeric glycosidic linkages. These technologies are often 
used in conjunction with the use of glycosidases or chemical techniques that cleave 
oligosaccharides based on well characterized linkages. Although, mass spectrometry has 
been an invaluable tool for glycomics, the stereoisomeric nature of carbohydrates makes 
it difficult to apply mass spec as a stand-alone method for the identification of 
monosaccharides. Therefore, the specific monosaccharides must be deducted from prior 
knowledge of existing glycans, metabolic pathways and expression profiles. Even after 
high quality sequence and linkage analysis, to obtain structural information, additional 
methods such as nuclear magnetic resonance (NMR) and X-ray crystallography must be 
employed [65].  
Unlike proteins that are the products of a highly conserved genetic code, there is 
no known similar code that reliably dictates the addition of monosaccharide units on 
glycans. Instead, glycosylation is influenced by dynamic factors such as the metabolic 
state of the cell or the expression and availability of the enzymes responsible for glycan 
synthesis. Quite often, different glycan processing enzymes will compete for substrates. 
This leads to differences in glycosylation within a single glycan attachment site on a 
protein, a phenomenon called microheterogeneity [66]. Predictive glycosylation sites 
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based on amino acid sequences are known, however, microheterogeneity makes it 
difficult to predict which glycan if any will be added to that site. An analysis of the site 
specific glycosylation of γ-glutamyl transpeptidase in human renal tissue identified 15 
different glycans [67]. Moreover, proteins that contain several glycosylation sites can 
display macroheterogeneity by the occupation of disparate glycans. For example, the 
Notch receptor is known to contain both N- and O-linked glycans [68]. As discussed 
previously, differences in the glycoforms of a given protein can lead to changes in 
cellular location, half-life, and binding partners. Regardless of the challenges, protein 
glycosylation is an important aspect of protein and cellular diversity that must be 
carefully studied. For these reasons, glycobiologists are constantly trying to develop new 
methods to more efficiently study the glycosylation of biological samples. Some of the 
common methods were discussed above. The next section focuses on the use of glycan-
binding proteins to study carbohydrate structure and function. 
 
1.4 LECTINS 
Carbohydrates, like DNA, are found in all existing life forms. Hence, all life 
forms also contain the proteins that recognize and bind to carbohydrates. One such 
category of proteins are the lectins, carbohydrate-binding proteins that are non-enzymatic 
and of non-immune origin (i.e. not antibodies). Lectins from plant sources were initially 
studied for their ability to agglutinate bloods cells. It was almost a half a century later 
when their hemagglutination properties were linked to carbohydrate binding and another 
ten years before their blood group specificity was described in the 1940s. Since then, 
glycan-lectin interactions have been shown to be important for protein trafficking, 
immunity, cellular recognition and homing. Pathogens such as viruses and bacteria utilize 
 18 
glycan-lectin interactions for host recognition and cellular adhesion [69-71]. As seen in 
the secretion of the highly toxic ricin from the castor oil plant ricinus comunis, the 
secretion of lectins can also serve as a protective mechanism.   
Lectins are classified into different families based on amino acid sequence 
homology of their carbohydrate recognition domains (CRDs). Members of the same 
family typically have an affinity for the same or similar carbohydrate structures but there 
are many cases where homologous CRDs recognize dissimilar structures. Multiple X-ray 
crystallography studies exist for lectins with their known binding partners. In general, the 
CRD of lectins that recognize N- and O-linked glycans consist of shallow binding 
indentations on the surface of the protein [72]. Therefore, lectins tend to bind to the 
terminal carbohydrate residues on the glycan with relatively low affinities (Kd values can 
be in the low millimolar range). However, because lectins often contain several CRDs or 
are multimeric, their multivalency serves as a mechanism for forming biologically 
relevant interactions [73]. Some lectins can be very specific whereas others may be more 
promiscuous in their glycan recognition. A well-known example of a highly specific 
lectin is the bird influenza virus hemagglutinin, which preferentially binds to NeuAcα2-
3Gal linkages and therefore does not typically infect human tracheal epithelia, which are 
rich in terminal NeuAcα2-6Gal epitopes [74]. 
 
Lectin Microarray Technology 
Traditionally, lectins have been used in assays such as histochemical staining, 
affinity chromatography and cell typing.  However, given the innate heterogeneity and 
complexity of most biological samples, a more extensive approach to studying these 
samples is needed. Taking a cue from DNA and antibody microarray technology, our lab 
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and a few others independently developed the lectin microarray to study the glycosylation 
patterns of biological samples in a more comprehensive and high-throughput fashion. In 
this method, multiple lectins with diverse specificities are covalently attached to a solid 
substrate in a microarray format which can then be probed with glycosylated samples 
[75]. Our lectin microarray consists of approximately 80 commercially available plant 
lectins and 10 recombinantly produced bacterial lectins printed onto a hydrogel slide in a 
24-subarray format. Each subarray is printed with 3 replicate lectin spots with each spot 
containing picoliter amounts of concentrated lectin solution. One microarray slide can 
therefore be incubated with 24 different glycosylated samples (Figure 1.6). After rinsing 
away any unbound material, the slide is scanned and the different patterns of flourescent 
spots correspond to the lectin binding and therefore glycosylation patterns of the samples 
[76-78]. The spots not only give a positive or negative output if a particular glycan is 
present or absent, but we can also semi-quantitatively compare carbohydrate epitope 
amounts. This technology has been successfully used in our lab and by others to analyze 
the glycomic content of pathogenic bacteria, HIV, mammalian cells and tissues, and other 





Figure 1.6: Schematic of the current lectin microarray technology. The lectins are 
printed on a hydrogel slide in a 24 subarray format so that 24 samples may 
be probed on one slide. Fluorescently labeled glycosylated samples are 
incubated on the array. After washing to removing unbound material, slides 
are scanned. The lectin binding pattern reveals the glycosylation profile of 
the sample. 
There are two kinds of methods typically applied in our lab for lectin microarray 
analysis. In the first and simpler method, single color analysis, we label our samples with 
a fluorescent dye such as cyanine-3 and probe one sample per subarray. Although the 
resultant lectin binding patterns provide us with information about the glycomic content 
of our samples, to do a more comparative analysis between samples, we use the 
ratiometric dual-color approach. In this method two different orthogonally labeled 
samples (cyanine-3 and cyanine-5 labeled) are incubated on the same array. These two 
samples can then competitively bind with the lectins on the array providing a ratiometric 
output between the two channels. Because slight differences in individual lectin activity 
 21 
and local background between arrays would not affect the ratio, we use this method for 
comparative analysis across multiple samples by using the same orthogonally labeled 
reference. An example of both a single-channel and dual-channel probed lectin array is 
provided in Figure 1.7. Thus, the ability to probe many samples at once and semi-
quantitatively measure glycomic content makes lectin microarray technology quite suited 
for a comparative glycomic analysis of a diverse set of microvesicles 
 
 
Figure 1.7: Example of a single-color and dual-color lectin microarray experiment. For 
both, 1.5 µg (by protein) of Cy-3 labeled Sk-Mel-5 microvesicles were 
probed. An equal amount of Cy-5 labeled H9 membrane was incubated with 
the microvesicles as the reference in the dual color experiment.  
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Chapter 2: Isolation and characterization of microvesicles  
2.1 INTRODUCTION 
Overview 
Previously, researchers in our lab effectively utilized lectin microarray technology 
to compare the glycosylation profiles of microvesicles, HIV particles and cell-membranes 
derived from three different human T- cell lines. From this analysis, Krishnamoorthy et 
al. identified a distinct glycomic signature in T-cell microvesicles that closely resembled 
the HIV glycome [79]. We wanted to know if this glycomic signature was typical of all 
or most human microvesicles or was exclusive to T-cell or hematopoietic cell vesicles. 
Identifying a pervasive microvesicle glycomic profile would have important implications 
for the role of glycans in microvesicle biogenesis and/or function. To investigate this, my 
work focused on examining the glycomic content of microvesicles derived from a diverse 
panel of biological sources. This chapter describes the characterization and isolation of 
microvesicles and is the first comparative analysis of the microvesicle yields obtained 
from multiple different cell lines. 
 
Methods for Microvesicle Isolation and Characterization 
It is now widely accepted that cells secrete various types of lipid-bilayer enclosed 
microvesicles that have the ability to deliver cellular content to surrounding recipient 
cells. These different particles are defined by physical characteristics such as size, 
density, lipid and protein content although the lines of classification are often blurred 
[83]. In general, there are two basic categories of cell secreted microvesicles defined by 
what is believed to be their mechanism of biogenesis. Exosomes are described as having 
an endosomal origin and are thought to be released after the fusion of multivesicular 
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bodies with the plasma membrane. There is no consensus on the size of exosomes but 
they are generally reported as being within the range of 20-200 nm in diameter [1]. A 
second type of microvesicle, most often called shedding microvesicles, is released to the 
extracellular environment by the outward budding of the plasma membrane. Shedding 
microvesicles (ectosomes) are typically described as being larger in size (up to 1 µm) 
than exosomes. However, several researchers have reported observing exosome-sized 
vesicles that bud from the plasma membrane [8]. A more detailed discussion on the 
biogenesis and properties of exosomes and shedding microvesicles is given in Chapter 1.  
The various physical characteristics of microvesicles have led to the adoption of 
multiple protocols for their isolation from cell culture and physiological fluids. These 
methods make use of the known size, density, shape and macromolecular content of 
microvesicles. To separate vesicles by size, researchers often perform a series of 
differential filtration or centrifugation steps or a combination of both. Vesicles smaller 
than 200 nm can be obtained by passage through a 0.2 or 0.1 µm filter or pelleted by 
ultracentrifugation at 100,000 x g while larger vesicles are obtained at slower speeds such 
as 10,000 x g [28]. Concerns about the integrity of microvesicles after applying force 
through a filter, has led to the adoption of filtration devices that makes use of both a 
centrifuge and filters for separation of vesicles by size [84]. There are, however, potential 
pitfalls to both of these isolation methods. The main problem with the ultracentrifugation 
methods is the high cost of equipment and maintenance. While filtration may seem to be 
a suitable alternative, there is a greater loss of sample associated with the use of filters for 
microvesicle isolation due to adherence of proteins to the filter membrane [8]. Another 
potential problem is the contamination of the sample with unwanted material such as 
vesicles of a larger or smaller size and precipitated proteins. Two common methods for 
obtaining a more homogeneous microvesicle population are the use of either sucrose 
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cushion or density gradient ultracentrifugation to separate vesicles by their density [85]. 
Although this leads to purer samples, there is substantial reduction in microvesicle yield. 
Lastly, researchers make use of known surface markers such as the tetraspanins, CD63 
and CD81. These proteins are typically found in exosomes and can be used to exclusively 
pull-down and isolate microvesicles containing exosomal markers. 
After isolation, microvesicles can be characterized by several methods. Since 
nano-sized microvesicles are too small to be imaged by most commonly used 
fluorescence and light microscopes, the gold standard for examining microvesicles is 
transmission or scanning electron microscopy. With electron microscopy images, the size 
and shape of the microvesicles can be noted as well as the identification of markers by 
immunogold labeling. Obtaining TEM images can be quite costly, and researchers most 
commonly look for a set of microvesicle markers by western blot analysis. Like the 
isolation and characterization methods, quantification of microvesicle amounts can be 
done in several ways. Often, microvesicles are quantified by protein or nucleic acid 
amount depending on the molecule or mechanism of interest. Although quantification by 
such methods is convenient, the assumption is made that microvesicles contain consistent 
amounts of protein or RNA. Alternatively, dynamic light scattering can be effectively 
used to quantify as well as measure the average size of microvesicles [86]. Fluorescence-
activated cell sorting (FACS) is another method of quantification, however, most flow 




2.2 RESULTS AND DISCUSSION 
 Isolation of microvesicles from a diverse panel  
To identify a microvesicle glycomic signature we needed a large and diverse 
panel. For this reason, we focused on members of the NCI-60, a set of 59 cancer cell lines 
obtained from human tissues that is maintained by the National Cancer Institute. We 
chose this set because of the diversity of cell types and their extensive characterization 
from numerous studies. In addition, we had these cell lines readily available due to a 
large-scale NCI-60 glycomic and genomic project currently being undertaken in our 
laboratory. The normal skin cell lines, and the human serum were chosen to rule out the 
possibility of a cancer specific glycan signature. The initial dataset for microvesicle 
isolation contained one renal cancer, two colon cancers, one breast cancer, two 
melanomas, three T-lymphomas, two normal skin cell lines, and human serum. 
Microvesicle yields were quantified by protein concentration. Approximately equal 
amounts of cell culture resulted in vastly different yields for the different cell lines, with 
Sk-Mel-5 producing the greatest amount of microvesicle protein per milliliter of culture 
(Table 2.1). Cancer and normal cell lines were cultured and microvesicles isolated from 









Cell Line Description 
Average Yield                            
(µg protein per ml 
of culture) Std Dev 
ACHN renal carcinoma 120.0 42.2 
H9* T-cell lymphoma NA 
 Jurkat * T-cell lymphoma NA 
 SupT1* T-cell lymphoma NA 
 HCT-15 colon adenocarcinoma 154.7 4.0 
HT-29 colon adenocarcinoma 142.7 48.4 
MCF-7 breast carcinoma 111.0 8.5 
Sk-Mel-5 melanoma 484.7 161.6 
Sk-Mel-28 melanoma 128.0 81.7 
Hs 895.Sk normal skin 75.0 2.0 
TE 353.SK normal skin  99.0 4.2 
Table 2.1: Isolation yields from panel of cell-derived microvesicles. * T-cells were 
cultured and microvesicles isolated by Dr. Lakshmipriya Krishnamoorthy.          
NA: Data not available. 
 
Because previous studies from our lab suggested that microvesicles may emerge 
from cell membrane microdomains defined by carbohydrates [79], we decided to 
compare the microvesicles to their parent cell membranes as well. The procedure for 
microvesicle isolation and cell membrane preparation is outlined in Figure 2.1. Large cell 
cultures of over 300 ml are needed to obtain usable (µg) amounts of microvesicles for 
most cell lines. The conditioned media or physiological fluid is taken through a series of 
differential centrifugation and/or filtration steps and microvesicles are obtained after 
ultracentrifugation at 100,000 x g. After removal of conditioned media, cells are washed 
to remove traces of microvesicles, harvested and lysed by sonication. Sonication causes 
disruption of the cellular membranes which then form smaller sized liposomes in 




Figure 2.1: Schematic of microvesicle isolation and cell membrane liposome 
preparation. Microvesicles and cell membrane are obtained from a matched 
set. 
 
Electron microscopy images show that the sonication process produces liposomal 
structures that range in size from approximately 50 to 200 nm in diameter, a size 
equivalent to the range of the microvesicles obtained from HT-29 and Jurkat cells (Figure 
2.2). The HT-29 and Jurkat microvesicles are within the reported size range of exosomes. 
Many of the vesicles display the typical cup-shaped morphology described in the 




Figure 2.2: Transmission electron images of microvesicles and membrane preparations 
isolated from HT-29 and Jurkat cells. The membrane preparation protocol 
generates liposomes within the size range of the microvesicles (arrows). 
Scale bar for all images is 200 nm. 
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In order to ensure that we were comparing analogous types of vesicles, the pellets 
from the conditioned media (the pelleted microvesicles) were probed for the presence of 
CD81 by western blot. The tetraspanin, CD81, is often observed in proteomic studies of 
exosomes and is therefore commonly used as an exosomal marker [4, 85]. The marker 
was present in the probed microvesicle samples (Figure 2.3). A problem with our 
isolation protocol (discussed below) was discovered before all samples were probed. We 




Figure 2.3: Microvesicles contain the exosomal marker CD81. Pellets obtained from 
cell conditioned media were probed for the presence of CD81 by western 
blot. 
 
Contamination of microvesicle samples with bovine serum glycans 
To isolate microvesicles, we followed an often cited protocol that recommends 
the cells be grown in “pre-cleared” growth medium before microvesicle isolation. This 
pre-clearing step, overnight ultracentrifugation of fetal bovine serum (FBS) containing 
media at 100,000 x g, should result in growth media that does not contain contaminating 
bovine vesicles or other protein products that may pellet with the cell-derived 
microvesicles [85]. After isolation and characterization of the panel of microvesicles and 
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cell membranes, samples were labeled with NHS-cyanine3 and incubated on the lectin 
microarray against an equal amount (1.5 µg protein) of NHS-cyanine5 labeled H9 cell 
membrane (Figure 2.4). H9 was chosen as a common biological reference because the 
cells are easily cultured in large quantities, enough to use on numerous arrays and the 
glycosylation profile of H9 gave a sufficient positive lectin binding pattern to be 
functional as a reference. In addition, H9 was previously used as the common reference 




Figure 2.4: Schematic describing the lectin microarray experiment for comparison of 
the panel of microvesicles and cell membranes using H9 membrane as a 
common reference. All samples are Cy-3 labeled and mixed with the Cy-5 
labeled reference for analysis on the array. 
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As a control, 300 ml of unconditioned pre-cleared media was subjected to a mock 
isolation, the pellet obtained was fluorescently labeled and incubated on the array in 
addition to the microvesicles and parent cell membranes.  Hierarchical clustering of the 
arrays revealed a problem with our initial dataset. Hierarchical clustering of the cell 
derived microvesicles revealed a prevailing lectin binding pattern (r = 0.53, N = 72, P < 
0.001). However, the pellet from the pre-cleared media showed a similar glycomic 
signature to the panel of microvesicles (Figure 2.5). We therefore could not be sure if the 
similarities between the cell-derived microvesicles were due to a contamination of bovine 
glycans. It is unknown whether the source of contamination is a result of large 
precipitates of soluble glycoproteins or from bovine vesicles that did not pellet with the 
overnight ultracentrifugation of the media. Because the lectin microarray cannot 
distinguish bovine from human glycans, the microvesicle samples isolated from pre-




Figure 2.5: Dual-color analysis reveals a contamination of the microvesicles with 
bovine serum glycoproteins. Microvesicles (MV, yellow bar) and their 
corresponding membranes (Mem) were analyzed with H9 as the common 
reference. Pre-cleared growth media was subjected to mock microvesicle 
pelleting, the pellet was examined on the array. Arrays and lectins were 
hierarchically clustered using the Pearson correlation coefficient (shown for 
selected clusters) with average linkage analysis. 
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Isolation and characterization of microvesicles from serum-free cell cultures 
As a result of the issues with pre-cleared FBS containing media, we decided to 
modify our isolation protocol so that contamination from serum would not be an issue 
and repeat our analysis to confirm the presence of a microvesicle glycomic signature. 
There are several alternatives to FBS that can be used as a supplement for growth media. 
However, these alternatives involve the use of a select number of growth factors which 
can be glycosylated and could in theory precipitate and pellet with microvesicles. To 
avoid the possibility of contamination, microvesicles were isolated from serum- and 
additive-free media. Previously, conditioned media was collected 48 hours post addition. 
However, because of concerns about cell stress in completely additive-free medium, 
conditioned media was collected 18-20 hours post addition. Even though cultures were 
increased from 300 ml to 360 ml, some cell lines (ACHN, MCF-7, Sk-Mel-28, Hs895.Sk) 
did not produce detectable or sufficient amounts of microvesicles. This is most likely due 
to the shortening of conditioning time from 48 hours to less than 24 hours as well as the 
decrease in protein content from the contamination of serum proteins. However, the 
possibility that factors are present in serum that may activate microvesicle production and 
secretion cannot be ruled out. Isolation of microvesicles from the normal skin cell line, 
TE353.Sk, was not attempted. Because of their slow doubling time and the lack of MV 
produced from the other normal skin cell line, Hs895.Sk, it was therefore assumed the 
TE353.Sk would not produce usable amounts of MV in a reasonable amount of time. 
Biological replicates for our samples were obtained by culturing three different 
passages of the cells and isolating MV and cell membrane from each passage separately. 
Microvesicles obtained from all cell lines and replicates were probed for the exosomal 
marker, CD81, as done previously. In addition, we probed for a second exosomal marker, 
CD63. Western blot images reveal that the microvesicles contain variable amounts of the 
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exosomal markers (Figure 2.6). Microvesicles from every cell line contained the 
exosomal markers. For consistency, passages that contained low amounts of the markers 
were not included in our glycomic analysis. Serum-derived exosomes lacked detectable 
amounts of CD63 and CD81 and were not included in glycomic analysis. Because of this, 
microvesicles from the physiological fluid, breast milk, were isolated to include a non-
culture and non-cancer element to the study. Breast milk microvesicles contained CD81 
and CD63 (Figure 2.6). The revised panel to be used for glycomic analysis is listed in 
Table 2.2 Transmission electron microscopy images of microvesicles and membrane 
preparations from serum-free cultured Sk-Mel-5 (Figure 2.7) reveal that they are in the 
range of 50 to 150 nm in diameter as previously observed for the HT-29 and Jurkat 
microvesicles and membranes isolated from pre-cleared media (Figure 2.2).  
It was surprising to find that our human serum pellets did not contain CD81 and 
CD63 as there are numerous research studies that claim that exosomes are present in 
human serum. Upon further investigation, I came across a research article in which 
vesicles were absent from the 100,000 x g pellets of human and mouse serum [89]. Other 
examples have since emerged indicating that certain circulating proteins and even 
microRNA, previously believed to be derived from microvesicles, are actually 
independent of vesicles [90]. This highlights the importance of a thorough 
characterization of pelleted samples, however I do not believe that exosomes are absent 
from all human sera. It has been found that cancer and immune disease elevate the levels 
of microvesicles found in blood so it is possible that our sample, obtained from a healthy 
donor, contained only trace amounts of microvesicles. Further studies are needed to 
determine the content of the pellets obtained from our human serum samples. It was 
interesting to note that despite the absence of CD63 and CD81, the human serum 
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microvesicles displayed a similar lectin binding pattern to all the other microvesicles in 
the panel (Figure 2.5).  
 
 
Figure 2.6: Western blot analysis of the pelleted serum-free cell conditioned media and 
physiological fluids reveals the presence of exosomal markers CD63 and 
CD81 in HCT-15 (HCT), HT-29 (HT), (Sk-Mel-5 (SkM5), Jurkat (Jurk), 
H9, SupT1 (SupT) and breast milk (BrM) derived microvesicles.  Human 




Figure 2.7: Transmission electron microscopy images of microvesicles and membrane 
preparations from serum-free cultured Sk-Mel-5 cells. Microvesicles have 
the typical size and morphology of exosomes. Cell-membrane liposomes 
from serum-free Sk-Mel-5 are similar in size and shape to the previously 
observed HT-29 and Jurkat liposomes derived from pre-cleared FBS-




H9* T-cell lymphoma 
Jurkat * T-cell lymphoma 
SupT1* T-cell lymphoma 
HCT-15 colon adenocarcinoma 
HT-29 colon adenocarcinoma 
MCF-7 breast carcinoma 
Sk-Mel-5 melanoma 
Breast Milk  Physiological fluid  
Table 2.2: Revised panel of microvesicle sources for glycomic analysis. All samples 
contained exosomal markers CD63 and CD81. Cell conditioned media was 
free of FBS. * T-cells were cultured by William Eng. 
 
Comparison of pre-cleared and serum free cultured microvesicles 
We wanted to know to what extent FBS contamination was influencing the 
glycomic profiles of microvesicles. To this end, we compared serum-free and pre-cleared 
derived samples by dual-color microarray analysis using H9 membrane as the common 
reference.  Microvesicles were compared by hierarchical clustering using the Pearson 
correlation coefficient as the distance metric between all samples. Cluster analysis 
(Figure 2.11) shows that the microvesicles as a whole are statistically similar (r = 0.554, 
N = 88, P < 0.0001, two tailed t-test). However, only the vesicles from HCT-15 and Sk-
Mel-5 are highly correlated (r > 0.85) with their serum-free (SF) counterparts. Biological 
replicates of microvesicles and cell-membranes are usually tightly clustered with a 
Pearson correlation coefficient of 0.85 or greater. For this reason, the panel of cell-





Figure 2.8: Hierarchical clustering of microvesicles from serum free (SF) and pre-




This chapter describes the isolation and characterization of microvesicles from a 
diverse panel of sources for the purpose of studying their glycomic content. After initial 
setbacks due to potential contamination from FBS, our panel was ultimately smaller than 
previously projected, with less cell lines and only one biological fluid. Microvesicles 
were nonetheless successfully obtained from two colon, three T-cell, and two skin cancer 
cell lines as well as breast milk from a healthy mother for glycomic analysis. Electron 
microscopy images demonstrate that our isolation protocol rendered microvesicles that 
are within the typical size range described of exosomes. With the exclusion of human 
serum the microvesicle panel contained the exosomal markers CD81 and CD63. 
However, further studies are needed before any conclusion of endosomal origin can be 
made as several labs including our own have produced evidence that exosome-sized 
particles may bud directly from the plasma membrane [25-27, 79]. In addition, there are 
considerably fewer proteomic studies of shedding microvesicles and therefore the 
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possibility cannot be ruled out that these particles may also contain CD81 and CD63. 
Vesicles budding directly from tetraspanin enriched plasma membrane domains have 
been observed [27].  
 
2.4 MATERIALS AND METHODS 
Cell culture 
The ACHN, HT29, HCT-15, MCF-7, Sk-Mel-5 and Sk-Mel-28 cell lines were 
purchased from the National Cancer Institute (Frederick, MD). The normal skin cell 
lines, Hs895.Sk and TE353.Sk, were purchased from ATCC. H9 and SupT1 were 
obtained from J. Bess (AIDS Vaccine Program, NCI, Frederick, MD). Jurkat-Tat-CCR5 
cells were obtained from Q. Sattentau (University of Oxford). Primary skin cells were 
cultured in DMEM with 10% (v/v) FBS (ATCC), all other cells were cultured in RPMI 
1640 (Lonza) with 2 mM L-glutamine and 10% (v/v) FBS (Atlanta Biologicals, 
Lawrenceville, GA). All cells were cultured at 37˚C with 5% CO2. Penicillin-
streptomycin (Mediatech, Manassas, VA) was added to the non-adherent T-cell lines 
which were cultured by William Eng and Dr. Lakshmipriya Krishnamoorthy. 
 
Breastmilk Collection  
Our collaborator, Dr. Karen D. Hendricks-Muñoz obtained human milk samples 
from a healthy 34 year old Caucasian mother who delivered a preterm infant at 30 weeks 
gestational age. This was the mother’s third pregnancy and delivery. The mother was 
rubella immune and negative for Hepatitis, HIV and Chlamydia infections with a history 
of infertility due to uterine adhesions. The sample used in this analysis was obtained by 
mechanical expression at 27 days post-partum, immediately frozen and stored at −20°C 
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until analysis. This research was performed with NYU School of Medicine Institutional 
Review Board approval and the mothers’ written informed consent.  
 
Microvesicle Isolation 
Cells were rinsed twice with Hank’s buffered salt solution (HBSS) (Mediatech, 
Manassas, VA) to remove traces of FBS and growth medium was replaced with either 
serum-free medium or pre-cleared growth medium. To pre-clear the FBS, media 
containing 20% FBS was ultracentrifuged at 100,00 x g for 16 h at 4˚C, serum free media 
was added to the supernatant to achieve a final concentration of 10% FBS. Media was 
then filter sterilized. After 48 h (pre-cleared) or 24 h (serum free), conditioned media was 
collected and microvesicles were isolated by differential centrifugation as described 
previously. Briefly, cell debris and larger vesicles were pelleted out of the media by 
sequential centrifugation (300 x g, 10 min, 2,000 x g, 20 min and 10,000 x g, 30 min; 
Beckman Coulter). The cleared supernatant was subjected to ultracentrifugation at 
100,000 x g for 1 h to obtain a microvesicle pellet. Microvesicles were resuspended in 
either PBS (0.1 M phosphate buffer, 0.15 M NaCl, pH 7.4) or Cy-labeling buffer (0.1 M 
NaHCO3, pH 9.3). A slightly altered protocol was utilized for the isolation of 
microvesicles from human breast milk and serum. Differential centrifugation (as above) 
of 2 ml of breast milk and varying amounts (14 -50 ml) of serum was followed by 
sequential filtration through 0.45 µm and 0.22 µm filters. The filtrates were overlayed 
onto a 30% sucrose cushion and centrifuged at 100,000 x g for 1 h.  The pellets were 
resuspended in PBS and centrifuged at 100,000 x g for 1 h. The washed pellet were then 
diluted in Cy-labeling buffer. The protein levels of all microvesicle preparations were 
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quantified using the micro-BCA assay (Thermo Scientific). Normal human serum was 
purchase from Lonza (catalog #14-402E).  
 
Cell membrane preparation 
Labeled cell membranes were prepared as described previously with some 
exceptions. After collecting conditioned media, cells were washed twice in cold PBS and 
either scraped (adherent cells) or resuspended (non-adherent cells) in cold PBS 
containing protease inhibitor cocktail. Cells were then sonicated on ice (3 x 5 s, 70% 
power, Branson sonicator) to disrupt cell membranes. Membranes were pelleted by 
ultracentrifugation at 100,000 x g for 1 h. The pellet was resuspended in Cy-labeling 
buffer and homogenized by sequential passing through 18- and 24- gauge needles. We 
determined the protein concentration using the DC protein assay (Bio-Rad). 
 
Cy3- and Cy5- labeling 
Samples were fluorescently labeled with 60 mg of Cyanine 3 (Cy3) or Cyanine 5 
(Cy5) mono reactive-NHS per mg of protein in Cy-labeling buffer for 30 min at room 
temperature with gentle rocking (GE Life Sciences). The labeling reaction was quenched 
by the addition of a Tris-buffered saline stock solution (2 M Tris-HCL, 1.2 M NaCl, pH 
6.8) to a final concentration of 250 mM Tris-HCl and 150 mM NaCl (final pH ~7.6-7.8) 
for 30 min. Microvesicle samples were used without further purification from the 
quenched excess dye. For cell membrane samples, excess dye was removed by dialyzing 
into PBS overnight at 4˚C. This prevented the high background observed with these 
samples when used after quenching alone, which is most likely due to the exposure of 
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hydrophobic lipids in unsealed membrane bilayers following the cell disruption. Protein 
concentrations for membrane samples were obtained after dialysis.  
 
Lectin Microarray Print.  
All lectins were purchased from either EY Laboratories (San Mateo, CA) or 
Vector Labs (Burlingame, CA) with the following exceptions: cyanovirin (CVN), 
scytovirin (SVN) and griffithsin (GRFT) were gifts from Dr. B. O’Keefe (NCI-
Frederick); galectin-9 was a gift from Dr. L. Baum (UCLA Medical School); and Gaf-D, 
PA-IL, PA-IIL, PapGII, PapGIII and RS-IIL were made recombinantly as previously 
described.  Three spots per lectin were printed using a Nanoplotter 2.1 piezoelectric 
printer (GeSIM, Germany) at 14˚C and 45% humidity. See Table 31. for lectin list, print 
concentrations and buffers. 
 
Microarray Hybridization and Analysis.  
Microarray slides were submerged in blocking buffer (50 mM ethanolamine, mM 
sodium borate ph 8.5) for 1 h followed by 3 washes with PBST (PBS with 0.005% 
Tween) and a final wash with PBS. The microarray slides were fitted to a 24-well frame 
(ArrayIt, Sunnyvale, CA).  Equal amounts (1.5 µg) of Cy3-labeled microvesicles were 
incubated with equal amounts of Cy5-labeled H9 reference membrane in 100 µl total 
volume PBST. Samples were hybridized to the lectin microarrays for 2 h at room 
temperature with gentle rocking. The individual subarrays were then washed with PBST 
for 5 x 5 min with a final 10 min wash in PBS. Slides were scanned and analyzed using a 
GenePix 4300B fluorescent slide scanner (Molecular Devices, Sunnyvale, CA) with 
GenePix Pro 7 software at a resolution of 5 µm. The photomultiplier (PMT) gain settings 
 43 
were 500 for the Cy3 channel and 450 for the Cy5 channel. For each channel, the 
background subtracted median fluorescence of the three replicate spots per lectin was 
tested for outliers using the Grubbs outlier test with alpha = 0.05. Arrays and lectins were 
hierarchically clustered by the log2 ratios using the Pearson correlation coefficient with 
average linkage analysis (Cluster 3.0). Clusters were visualized with Java Treeview. If 
the Pearson correlation values were statistically significant (P < 0.0001 for a two tailed t 
test, DF = N-2, calculated using http://faculty.vassar.edu/lowry/tabs.html#r ) then arrays 
were considered to be statistically similar.  
 
Western Blots  
Microvesicle and cell membrane proteins (3 µg of protein) were separated by 
SDS-PAGE under non-reducing conditions and transferred to nitrocellulose membrane. 
Samples were probed with antibodies to CD63 (1:500 dilution) (RFAC4, Millipore, 
Billerica, MA) and CD81 (1: 500 dilution) (H-121, Santa Cruz Biotechnology, Santa 
Cruz, CA), followed by incubation with the appropriate HRP-conjugated secondary 
antibody (1:10,000 dilution) (Bio-Rad, Hercules, CA). Blots were visualized using 
Supersignal West Pico or Supersignal West Femto Chemiluminescent Substrate (Thermo 
Scientific) and a GBox gel imaging system (Syngene).  
 
Electron Microscopy 
Images were obtained from the New York University Langone Medical Center 
Office of Collaborative Sciences Microscopy Core. Samples were negatively stained with 
1% Uranyl Acetate in ddH2O on 400 mesh Cu grids coated with a Carbon membrane. 
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Grids were viewed on a Philips CM12 tungsten emission TEM at 120kV and imaged with 
a Gatan 4k x 2.7k digital camera. 
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Chapter 3:  Glycomic Profiling of Microvesicles 
3.1 INTRODUCTION 
Overview 
Our initial glycomic analysis of microvesicles using lectin microarrays hinted at 
the possibility of the presence of a conserved glycomic signature for these particles. 
However, the discovery of contamination from FBS derived glycans complicated this 
analysis and required a different method of generating vesicles. After successful isolation 
and characterization of a panel of serum-free derived microvesicles, this chapter focuses 
on the analysis and comparison of their glycomic content using lectin microarrays. 
 
Glycosylation of microvesicles 
The knowledge that cells release vesicles that carry and transfer bioactive cellular 
content has led to enthusiastic interest in these particles for their diagnostic and 
therapeutic potential [91]. Because of this, there has been a surge of studies that profile 
the proteomic and RNA content of microvesicles from numerous sources. Many of the 
findings from these studies are compiled in Exocarta, an open source database of 
exosomal proteome and RNA data [92]. In contrast to the wealth of proteomic and RNA 
information gathered from multiple studies, very little is known about the glycomic 
content of these vesicles. Much of what is known about microvesicle glycosylation 
derives from research done on individual secreted glycoproteins. Interestingly, several of 
these studies have demonstrated that microvesicles contain proteins with distinct 
glycoforms than those found intercellularly. For instance, the secreted protease ADAM-
10 was found to display an enrichment of complex N-linked glycans in the exosomal 
fraction when compared to the cellular enzyme [93]. This and other glycoprotein studies 
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have led to the belief that glycosylation may be a determining factor for trafficking of 
glycoproteins to particular secreted vesicles. In order to make this a more compelling 
argument, a comprehensive glycomic and glycoproteomic study is needed. 
Not suprisingly, researchers are beginning to find that glycosylation on 
microvesicles can have an effect on biological function. For example, when investigating 
the role of microvesicle-secreted synapsin on neurite outgrowth and neuronal survival, 
Wang et al. found that this process was dependent on the presence of oligomannose 
structures on synapsin [94]. In another study, human tracheobronchial derived vesicles 
revealed the importance of α2-6 sialylated mucins for neutralizing influenza virus [95]. 
Recently, Escrevente et al looked for the presence of glycans in microvesicles from three 
different cell lines, ovarian carcinoma, embryonic kidney and neuroglioma cells, using 
the lectins SNA, MAL and ConA and demonstrated the presence of α2-6 and α2-3 sialic 
acid and α-mannosyl branched glycans. In addition, they found that pre-treatment of 
SKOV3 cells with mono- and disaccharides decreased the cellular uptake of the vesicles. 
However, desialylation of microvesicles using Neuraminidase did not significantly 
reduce uptake [96]. This and other studies like it hint at the possibility that glycans may 
be involved in cellular recognition or uptake, much like viruses, which have similar 
characteristics to microvesicles, are known to utilize glycan-lectin interactions for these 
processes [97]. Using lectin microarrays, our lab previously described the glycosylation 
profiles of T-cell derived microvesicles, membranes and HIV. Comparing the three 
profiles revealed many similarities between the virus and microvesicles [79]. This study 
is yet another clue that microvesicles may share cellular exit or entry mechanisms or both 
that make use of glycan-lectin interactions. Given the purported role of microvesicles in 
intercellular communication and their potential for use in diagnostics, it is important to 
learn more about the glycosylation of these particles.   
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3.2 RESULTS AND DISCUSSION 
Single color analysis 
The panel to be analyzed on the lectin microarray, a total of 21 samples, was 
comprised of microvesicles from serum-free cell culture, their parent cell membranes and 
breast milk microvesicles. As a quality control to detect any lectin print issues or 
anomalous lectin binding, the first slide of every print batch is tested by incubation with a 
panel of fluorescently labeled glycoproteins. If the glycoprotein-lectin binding pattern is 
adequate, each slide thereafter is incubated with at least two glycoproteins. A total of two 
slides were used for the single color glycomic analysis of the panel. It is important to 
determine if differences in lectin activity exist between slides, particularly for single 
color analysis because this method is more sensitive to these types of issues. To test the 
slides for consistency in lectin printing and activity, the glycoprotein data were 
hierarchically clustered using the uncentered variant of the Pearson correlation and 
average linkage analysis. All replicate glycoprotein samples had a Pearson correlation 
coefficient of above 0.95 (Figure 3.1). This high correlation between all arrays gave us 
confidence that the single color samples could be compared using two slides.  
For the single color analysis, equal amounts of Cy3-labeled microvesicles and cell 
membranes, 1.5 µg based on protein concentration, were probed on the lectin array. An 
example of the raw single color data for Sk-Mel-5 microvesicles and membranes is given 
in Figure 3.2. Some of the notable differences and similarities between the samples are 
clearly visible by eye and highlighted in the figure. However, there are some 
inconsistencies with the lectin binding data. In SkMel-5, WGA, TJA-I (sialic acid 
binding lectins), NPA (a high mannose lectin), and DSA (a polyLacNAc binder) appear 
to bind microvesicles and the corresponding cell membrane preparations at similar levels 
as measured by median fluorescence intensity. In contrast, lectins with similar specificity 
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profiles (α2-6 sialic acid: SNA; high mannose: HHL, PSA) have a preference in binding 
to the microvesicles. This suggests that the former lectins cannot distinguish differences 
between microvesicles and membranes because they are completely saturated and are 
outside the linear range of detection. This is a problem that can sometimes occur because 
it is difficult to predict what concentration will be within the linear binding range for all 
lectins and samples. A way to circumvent this problem is by the ratiometric dual-color 
approach, in which competitive binding between the sample and a common reference 
enables comparison of the relative binding levels. This method enhances sensitivity to 
differences as well as true similarities between samples. Because of this, the 
microvesicles were analyzed by the dual-color approach as well and this analysis is 




Figure 3.1: Assessment of slide to slide variations in lectin quality by incubation with 
glycoprotein standards. Arrays were analyzed by hierarchical clustering 
using uncentered correlation and average linkage analysis. Correlation 




Figure 3.2: Comparison of SkMel-5 MV and MB on the lectin microarray demonstrates 
exclusion (green block) and enrichment (red blocks) of glycan epitopes in 
MV as well as lectins that bind equally to both (yellow block). Although it 
may appear that DSA preferentially binds to the membrane, fluorescence 
intensities for the two samples are approximately the same since spot 
circumference does not heavily influence the median fluorescence 
calculated by the Genepix program. 
 
To observe the glycosylation profiles of the entire panel, the lectin values were 
clustered using the program Cluster 3.0 but arrays were manually arranged so that 
microvesicles and membranes were segregated (Figure 3.3) [98]. Biological triplicates 
(three different passages) were incubated for the two cell lines from the panel that 
produced the highest amount of microvesicles, Sk-Mel-5 and HCT-15. The data was not 
normalized so that an unaltered representation of the lectin binding pattern is shown. The 
heat map displays actual fluorescence intensities of the bound samples to the lectin spots. 
The heat map reveals that the microvesicles are generally enriched in high mannose 
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(HHL, PSA, NPA, SVN, UDA), complex N-linked glycan (Calsepa, LcH, PHA-E, TL), 
α2-6 sialic acid (SNA, TJA-I) and polyLacNAc (LEA, DSA) epitopes but do not contain 
substantial amounts of terminal GalNAc (CAA, DBA, SBA, SJA, BPA), blood group A 
or B (EEA, LTL) compared to the cell membranes.  
The breast milk microvesicles displayed overall lower fluorescence intensities 
than the rest of the panel (Figure 3.4). This may be due to breast milk microvesicles 
having lower glycosylation levels, however, I do not believe this to be the case. As 
mentioned previously, equal amounts of microvesicles are hybridized to the array based 
on protein concentration. Because the yields from microvesicle sedimentations are 
typically less than 100 µg, the sample is conserved by obtaining protein concentrations 
from diluted samples. Concentrations are determined by the Pierce Micro BCA protein 
assay which can accurately detect low µg/mL concentrations of protein samples in a 
microplate format within the linear range of 2 - 20 µg/mL. The concentration of the 
breast milk microvesicles (assay performed in triplicate) was 2.0 µg/mL with a standard 
deviation of 0.165. With the standard deviation, the concentration of the sample was 
below the linear range of the standard curve. This was the only sample that fell below the 
linear range. Therefore it is quite possible that the Micro BCA assay gave an innacurate 
protein concentration for the breast milk microvesicles. Despite the overall lower 
fluorescence intensities of the lectin spots, the breast milk microvesicles display a 
binding pattern that is similar to the cell derived vesicles (Figures 3.3 and 3.4) with 
recognition of α2-6 sialic acid (SNA, SNA-I, TJA-I), complex N-linked glycans (LcH, 
calsepa), polylactosamine (DSA) and high mannose glycans (NPA, PSA). However, not 
all of the lectins that recognize these epitopes were visibly positive (yellow on the heat 
map) for binding to the breast milk sample. I believe this inconsistency is due to the 
possible lower than calculated protein amount that was hybridized to the array.  
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Figure 3.3: Microvesicles and cell-membranes have discrete glycomic profiles. Equal 
amounts (1.5 µg by protein) of Cy3-labeled samples were added to the lectin 
microarray. Lectins were hierarchically clustered by using the Pearson 
correlation coefficient as the distance metric and average linkage analysis (n 
= 74 lectins). Heat map is shown. Yellow indicates median fluorescence 
units > 500 and blue indicates median fluorescence < 500. Abbreviations: 




Figure 3.4: Lectin binding pattern of Cy3-labeled microvesicles from breast milk, HCT-
15 and Jurkat. Protein concentration was determined by Pierce Micro BCA 
protein assay and 1.5 µg of protein were probed. Breast milk microvesicle 
binding pattern has overall lower fluorescence intensity. 
 
Lectin binding on the array is carbohydrate specific 
The labeled glycosylated samples probed on the arrays produced lectin binding 
patterns. To test if these patterns are the result of specific carbohydrate-lectin 
interactions, several control experiments were performed. The Sk-Mel-5 cell line was 
chosen for control experiments because this cell line produced the greatest quantity of 
microvesicles. The arrays were pre-treated with mono- and disaccharides before addition 
of labeled Sk-Mel-5 microvesicles. The final concentration of the sugars after the 
addition of the sample was 100 mM which is the concentration that researchers typically 
use in lectin inhibition experiments. Lectin inhibition was determined by percent decrease 
in spot fluorescence intensity. The heat map in Figure 3.5 shows the carbohydrate-based 
inhibitions of the Sk-Mel-5 binding lectins. For ease of interpretation the lectins are 
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ordered on the heat map based on their broad mono- and disaccharide specificities. 
Complete inhibition was not expected as lectin affinity and avidity for carbohydrate 
moieties in a cellular or biological context is typically higher than for mono- and 
disaccharides. Generally, lectins were inhibited according to their specificities. Several 
lectins were inhibited by more than one sugar, for example, Calsepa, ConA, LcH and 
UEA-II, these lectins are known to bind more than one carbohydrate epitope. The lectins 
PHA-E, TL and AMA recognize branched, bi- and tri-antennary structures and, as 
expected, were very weakly or not at all inhibited. These results confirm that the lectins 
on the array are binding to the samples based on carbohydrate interactions.  
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Figure 3.5: Mono- and disaccharide inhibition of lectins on the array shows lectin 
binding is specific. Lectin arrays were preincubated with 200 mM GlcNAc, 
fucose, mannose or lactose for 30 min before addition of labeled SkMel-5 
MV (final sugar concentration was 100 mM). Heat map shown as a 
percentage of the untreated Sk-Mel-5 fluorescence values. 
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Several other control experiments were performed to confirm the specificity of 
lectin binding. Labeled Sk-Mel-5 microvesicles were treated with one of three 
glycosidases: EndoHf, which cleaves within the core of high mannose and hybrid N-
linked glycans, PNGaseF, which removes all N-linked glycans and Neuraminidase, which 
cleaves sialic acids linked α2-3, α2-6, or α2-8. Typically, glycoproteins are first 
denatured before treatment with glycosidases to allow for better access to the cleavage 
site. However, to keep the vesicles intact, the denaturing step was omitted and the 
samples were enzymatically treated for a longer period of time (18 h). Because the 
samples were not denatured before treatment, it is possible that not all cleavage sites were 
accessible to the enzymes. After glycosidase treatment, microvesicles were probed on the 
lectin microarray and compared to untreated controls. Figures 3.6 and 3.7 show the 
effects of enzyme treatment by a representative panel of lectins that preferentially bind to 
microvesicles. Treatment of SkMel-5 microvesicles with Endo Hf decreased binding to 
mannose lectins (NPA, HHL) but did not significantly affect binding of lectins with a 
specificity for complex structures (TL, Calsepa). In contrast, PNGase F significantly 
reduced the binding of lectins to complex, polyLacNAc, mannose and α2-6 sialic acid 
epitopes demonstrating that these lectins are binding to N-linked glycoproteins. The lectin 
LEA, which recognizes polyLacNAc containing glycans, did not show a great decrease in 
binding to the microvesicles after PNGaseF treatment. Therefore, the possibility cannot 
be ruled out that there are multiple sources of polyLacNAc glycans in the vesicles: 







     
B  
    
Figure 3.6: Glycosidase treatment of microvesicles confirms specificity of lectins. Cy3-
labeled SkMel-5 MV were treated with (A) EndoHf and (B) PNGaseF prior 
to incubation on the array. Values are expressed as a mean ± SD of replicate 
spots. Statistically significant differences are indicated by their p-values: * p 
< 0.05; **p < 0.001; *** p < 0.0001 calculated using the unpaired t-test. 
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Because of their affinity for negatively charged structures, many sialic acid 
binding lectins bind to sulfated carbohydrates as well. To test if the signature seen for 
microvesicles was due to the presence of α2-6 sialic acid, labeled Sk-Mel-5 vesicles were 
treated with neuraminidase before incubation on the array. Fluorescence intensity 
significantly decreased in α2-6 sialic acid binding lectins (Figure 3.7) but there was no 
change in α2-3 sialic acid binding lectins. This tells us that the α2-6 specific lectins are 
binding to sialic acid but the lectins that recognize α2-3 are possibly binding non-
specifically. Additionally, while most other non-sialic acid binding lectins on the array 
were unaffected by neuraminidase treatment (data not shown) there were some Gal and 
GalNac specific lectins (represented by VVA and WFA) that increased in binding. This is 
most likely due to exposure of these epitopes after the removal of sialic acid.  
 
 
Figure 3.7: Neuraminidase treatment of SkMel-5 MV demonstrates specificity of sialic 
acid binding lectins. Labeled MV were treated with Neuraminidase prior to 
incubation on the array. Values are expressed as a mean ± SD of replicate 
spots. Statistically significant differences are indicated by their p-values: * p 
< 0.05; **p < 0.001; *** p < 0.0001 calculated using the two-tailed t-test. 
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Dual color analysis using a common reference 
Although single color analysis provided information about the presence or 
absence of certain glycans in microvesicles and cell membranes, for a true comparison of 
the relative binding levels between samples we implemented dual color analysis using a 
common reference. In this method, competitive binding of the sample and a common 
reference gives a ratiometric output. This increases sensitivity to glycomic differences 
among samples and decreases sensitivity to variations between arrays. The biological 
reference used for comparative analysis was Cy5-labeled H9 cell membrane preparations. 
Glycoprofiles of the panel were obtained by incubation of equal protein amounts of Cy3-
labeled sample against an equal amount of reference. All samples were normalized by 
setting the median equal to zero for each channel (median centering). This was done for 
several reasons. First, as discussed previously, the fluorescence pattern of breast milk 
microvesicles was less intense compared to the rest of the samples. Second, because of 
the limited quantities of microvesicles produced from most cell cultures, loss of sample is 
avoided by quenching the labeling reaction with tris base instead of removing excess dye 
by dialysis or filtration. This means that a dye to protein ratio of the labeled microvesicles 
cannot be accurately calculated and controlled for all samples. Finally, to account for dye 
bias between the Cy3 and Cy5 channel, we typically hybridize a dye swapped pair on the 
array and then calculate the yang correlation for that pair [80]. However, again because of 
the quantities of the microvesicles, this analysis could not be done with a dye swapped 
pair. For these reasons, the data were median centered to accurately compare the samples. 
This type of global normalization is typical of microarray analysis and addresses 
systematic variations that are not biologically relevant [99]. 
Hierarchical clustering of the arrays using the Pearson correlation revealed that all 
but the Jurkat microvesicles clustered together and away from their corresponding cell 
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membranes (Figure 3.8). The cluster was statistically similar by two-tailed statistical 
analysis of the Pearson correlation value (r = 0.64, N = 75, P < 0.0001). The reason that 
Jurkat microvesicles cluster more closely with the parent cell membrane is unknown. One 
possibility is that since Jurkat cells have truncated O-glycosylation synthesis pathways, 
this may account for the differences between Jurkat microvesicles and the rest of the 
panel [100]. Upon clustering the microvesicles and cell membranes separately (Figure 
3.9), a conserved lectin binding pattern for the entire panel of microvesicles is revealed (r  
= 0.57, N=75, P < 0.0001). In contrast, clustering of the parent cell membranes did not 
show a conserved glycomic signature (r = 0.25, N = 75, P = 0.03). Giving confidence to 
the reproducibility of our data, all biological replicates tightly clustered with a correlation 
coefficient of r = 0.91 or greater. Included within the microvesicle cluster are the breast 
milk derived samples. Because this sample was obtained from human physiological fluid, 
this suggests that the conserved glycomic pattern observed is neither specific to cancer 
derived vesicles nor a phenomenon of the cell culture conditions. 
Dual color analysis improved the sensitivity of some of the lectins that were 
previously outside of the linear range of detection. Whereas the single color analysis 
portrayed binding to WGA, TJA-I, DSA and NPA to be approximately equal between 
Sk-Mel-5 microvesicles and membranes, ratiometric analysis revealed the expected 
differences between the two due to the enrichment of α2-6 sialic acid, polylactosamine 
and high mannose epitopes in the microvesicles. In addition, dual color analysis revealed 
two sets of GalNAc-specific lectins with divergent behaviors. The first set (DBA, BPA, 
SBA, VVA), bind to terminal - and -GalNAc epitopes such as Blood Group A and 
were previously identified in single color analysis as displaying lower binding to the 
microvesicles than the membranes. A second group of GalNAc binders (MNA-G, MPA, 
SNA-II, IRA, HPA, AIA) identified by dual color analysis revealed the enrichment of 
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terminal -GalNAc structures, such as the Tn antigen, in most microvesicles. Overall, the 
conserved microvesicle signature consisted of an enrichment of high mannose, complex 




Figure 3.8: Hierarchical clustering of the microvesicle and membrane glycomes using 




Figure 3.9: Ratiometric lectin microarray comparison using H9 membrane as a 
reference. Arrays were hierarchically clustered using the Pearson correlation 
coefficient as the distance metric and average linkage analysis (n=75 
lectins). Heat map is shown. Red indicates greater than the median; green 
indicates less than the median.  Select Pearson correlation values are shown 
on the tree. SkMel-5 (Sk), HT29 (HT), HCT-15 (HC), SupT1 (S), Jurkat (J), 
breast milk (B). 
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In addition to the conserved signature, microvesicles displayed some differences 
in their glycosylation (Figure 3.10). For the cell culture derived microvesicles, these 
differences are clearly a reflection of the parent cells. For example, HCT-15 and HT29 
cells have lower levels of α-2,6 sialic acid in their membranes when compared to the 
entire panel of cell lines and consequently display lower levels overall of this epitope in 
their cognate microvesicles (SNA, SNA-I and TJA-I). Additionally, SkMel-5 membranes 
did not bind to blood group H specific lectins (PTL-II, TJA-II, AOL, UEA-I) and the 
absence of this epitope is also seen in the microvesicles. However, blood group H is 
clearly abundant in both HCT-15 membranes and microvesicles and seems to be enriched 
in all but the Sk-Mel-5 vesicles. Breast milk microvesicles also displayed differences in 
their glycosylation profiles with binding to some Gal (PNA, PA-IL), GlcNAc (GafD) and 
GalNAc (SJA, VVA) specific lectins.  
 
 
Figure 3.10: Microvesicles display some differences in glycosylation. Arrays were 
analyzed as previously described in Figure 3.9. SkMel-5 (Sk), HT29 (HT), 
HCT-15 (HC), SupT1 (S), Jurkat (J), breast milk (B). 
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3.3 CONCLUSIONS   
Using lectin microarray technology, I was able to characterize and compare the 
glycosylation profiles of microvesicles from a diverse panel of sources. In doing so, I 
found that the microvesicles were enriched in many of the same types of carbohydrate 
epitopes. If making an analogy between the glycome and proteome of these particles, one 
could assume that microvesicles from diverse sources share certain typical traits but are 
largely a miniature copy of the parent cell. However, this did not seem to be the case in 
our glycomic comparison as most microvesicles, with the exception of Jurkat derived, 
were quite divergent from their parent cell membranes. Glimpses of the glycosylation 
profiles of microvesicles had been previously observed for individual glycoprotein 
studies, for ovarian microvesicles using three lectins, and on T-cells using the lectin 
array. Our work corroborated with many of these studies by identifying the presence of a 
high mannose, polylactosamine, α2-6 sialic acid and complex N-linked glycan signature 
in microvesicles. Although the reason for this conserved signature is unknown, it is very 
likely that the glycosylation profiles of microvesicles serve a biologically significant 
purpose. The presence of α2-6 sialic acid is known to increase the serum half-life of 
many circulating proteins such as follicle stimulating hormone (FSH) and acetyl choline 
esterase (AChE) [101, 102]. Since microvesicles are found in various physiological 
fluids, they could potentially be utilizing sialic acids to prolong their half-life as well. It 
will be interesting to investigate if the biological relevance of this conserved glycome is 
seen for individual glycoproteins.  
The lectin microarray allowed for the analysis of multiple samples in small 
quantities and was a useful tool for the comparative glycomic analysis of microvesicles. 
However not all of the analysis of these particles was completely clear. For example, the 
reason for the divergent behavior of certain αGalNAc binding lectins is unknown. This is 
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most likely due to the more intricate binding preferences of the lectins together with the 
subtle differences in glycosylation of the samples. Based on the fact that we see αGalNAc 
enriched in the microvesicles, the epitope that is excluded is most likely βGalNAc. The 
fact that many of the lectins on our array have somewhat promiscuous binding 
specificites can also be a problem. Our lab is currently working on solutions to these 
issues by implementation of recombinant lectin technology [103, 104]. 
Exosomes, and to a lesser known extent, ectosomes, have been shown to contain 
certain protein markers found in all or most studied samples. However, multiple 
proteomic studies and meta-analyses have revealed an immense variability in protein 
content, even within vesicles of the same type (e.g. urine microvesicles). This is one of 
the challenges for clinicians interested in the use of microvesicles as biomarkers. 
Considering the diversity of the proteomic content of microvesicles as well as the cell 
type differences in plasma membrane glycosylation, one would expect the same level of 
variability in the glycome. In this regard, the conserved glycomic profile of microvesicles 
is surprising and may imply that glycosylation is a signal for sorting of glycoproteins and 
glycolipids to these particles. The focus of the next chapter is to investigate the origins of 
this conserved microvesicle glycan signature. 
 
3.4  MATERIALS AND METHODS 
Microvesicle isolation and membrane preparations 
All samples for lectin microarray analysis were obtained as previously described 
in Chapter 2.  
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Lectin microarray print 
All lectins were purchased from either EY Laboratories (San Mateo, CA) or 
Vector Labs (Burlingame, CA) with the following exceptions: cyanovirin (CVN), 
scytovirin (SVN) and griffithsin (GRFT) were gifts from Dr. B. O’Keefe (NCI-
Frederick); galectin-9 was a gift from Dr. L. Baum (UCLA Medical School); and Gaf-D, 
PA-IL, PA-IIL, PapGII, PapGIII and RS-IIL were made recombinantly as previously 
described. Three spots per lectin were printed using a Nanoplotter 2.1 piezoelectric 
printer (GeSIM, Germany) at 14˚C and 45% humidity. See Table 3.1 for lectin list, print 
concentrations and buffers. 
 
Microarray sample incubation  
Microarray slides were submerged in blocking buffer (50 mM ethanolamine, mM 
sodium borate ph 8.5) for 1 h followed by 3 washes with PBST (PBS with 0.005% 
Tween) and a final wash with PBS. The microarray slides were then fitted to a 24-well 
frame (ArrayIt, Sunnyvale, CA). For single color experiments, we added 1.5 µg (by 
protein concentration) of labeled sample in a final volume of 100 µl in PBST to each 
subarray. For dual color experiments, 1.5 µg of Cy3-labeled microvesicles were 
incubated with equal amounts of either Cy5-labeled H9 reference or Cy5-labeled parent 
membrane in 100 µl total volume PBST. The order of the samples was randomized on a 
total of two slides for all dual color assays. Labeled glycoprotein standards were 
hybridized on all slides as controls and no statistical difference in lectin activity was 
observed between slides.  Samples were hybridized to the lectin microarrays for 2 h at 
room temperature with gentle rocking. The individual subarrays were then washed with 
PBST for 5 x 5 min with a final 10 min wash in PBS. Slides were dried spinning for 1 
min on a slides spinner. Slides were scanned and analyzed using a GenePix 4300B 
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The background subtracted median fluorescence of the three replicate spots per 
lectin was tested for outliers using the Grubbs outlier test with alpha = 0.05 (Microsoft 
Excel). For single color analysis, the average fluorescence of the replicate spots was 
calculated. For dual color analysis, the log2 values of the average fluorescence of the 3 
replicate spots were median centered over the array in each channel to account for 
differences in labeling efficiency. Misprints and lectins with signal to noise ratios (SNR) 
of less than 5, as determined by the GenePix Pro 7 software, in 90% or more of samples 
were excluded from the cluster. The log2 values of the average fluorescence of the 3 
replicate spots were median centered over the array in each channel to account for 
differences in labeling efficiency. The resultant datasets (arrays and lectins) were 
hierarchically clustered by the log2 ratios using the Pearson correlation coefficient with 
average linkage analysis using Cluster 3.0 [98] and visualized with Java Treeview [105]. 
Arrays were considered to be statistically similar if P < 0.0001. P values were obtained 
by employing a two tailed t test (N = number of lectins, r = Pearson correlation 
coefficient, Df = N-2) using the online statistical calculator: 
http://faculty.vassar.edu/lowry/tabs.html#r.  
  
Mono- and disaccharide inhibitions 
Subarrays were incubated with 50 µl of 200 mM fucose, lactose, mannose or 
GlcNAc in PBS for 30 minutes with gentle agitation. Negative controls were incubated in 
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50 µl PBS. After incubation 1.5 µg of Cy-3 labeled Sk-Mel-5 microvesicles in 50 µL of 




All enzymes were purchased from New England Biolabs. Cy3-labeled 
microvesicles (3 µg) were treated with either 1.5 kU EndoHf cloned from Streptomyces 
plicatus, 100 U Neuraminidase cloned from Clostridium perfringens or 1 kU PNGaseF 
purified from Flavobacterium meningosepticum per µg of microvesicle protein in the 
manufacturer provided buffer without the addition of detergent at 37˚C for 18 h.  
Negative controls were mock treated with enzyme buffer and incubated at 37˚C for 18 h.  
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AAA  Anguilla anguilla 1000 Fuc α-Fuc 
PNA Arachis hyogaea 500 Gal Terminal β-Gal  
AIA Artocarpus intergrifolia (Jacalin) 500 Gal 
α-GalNAc not substituted at 
C-6  
BPA Bauhinia purpurea 500 Gal 
Galβ1-3 or GalNAcβ1-4 more 
weakly 
Con A  Canavalia ensiformis  500 Man 
Branched and terminal 
mannose, terminal GlcNAc 
CCA Cancer antennarius 500 Lac 
9-O-Acetyl NeuAc and 4-O-
Acetyl NeuAc 
CAA Caragana arborescens 500 Gal GalNAc or Gal  
CPA Cicer arietinum 1000 Lac Complex 
CA Colchicum autumnale 500 Gal 
Terminal  β-Gal, α- and β-
GalNac  
DSA  Datura stramonium 500 Lac 
GlcNAcβ1-4GlcNAc 
oligomers, polyLacNAc  
DBA Dolichos biflorus 500 Gal 
α- and β-GalNAc  
(particularly sialylated 
branched structures) 
ECA Erythrina cristagalli 500 Gal 
GalNAcβ1-4GlcNAc, Galβ1-
4GlcNAc 
EEA  Euonymus eurpaeus 1000 Lac Blood Groups B and H  
GNA Galanthus nivalis  1000 Man Terminal Manα1-3  
SBA Glycine max  500 Gal Terminal α- or β-GalNAc 
GS-I Griffonia simplicifolia I  500 Gal a-Gal, some GalNAc  
GS-II Griffonia simplicifolia II  500 GlcNAc Terminal GlcNAc  
HPA Helix pomatia 500 Gal  Terminal α-GalNAc 
LcH Lens culinaris 1000 Man Complex and high mannose 
LFA Limax flavus 500 Lac α-NeuAc (O-glycans) 




3 GlcNAc  
LEA Lypersicon esculentum 500 GlcNAc 
β1-4GlcNAc oligomers, 
polyLacNAc 
LPA  Limulus polphemus 500 Lac α-NeuAc 
MAA Maackia amurensis  500 Lac NeuAcα-2,3 
NPA Narcissus pseudonarcissus 1000 Man Terminal and internal Man 
LBA Phaseolus lunatus 1000 Gal 
GalNAcα1-3[Fucα1-2]Gal 
(Blood A) 
PHA-E  Phaseolus vulgaris-E 500 Lac 
Complex N-linked  (bisecting 
GlcNAc) 
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PHA-L Phaseolus vulgaris-L 500 Gal 
 Complex trianntenary N-
linked glycans 
PSA Pisum sativum 1000 Man Man 
AOL  Aspergillus oryzae 1000 Fuc 
Fucα1-6 (core fucosylation), 
Fucα1-2Gal  
PTA Psophocarpus tetragonolobus 500 Gal Gal, GalNAc 
RPA Robinia pseudoacacia 1000 Lac Complex 
SNA Sambucus nigra  500 Lac NeuAcα2-6, (Lac core)  
SNA-II Sambucus nigra-II 500 Gal 
Gal-NAcα linked to C-2, C-3, 
or C-6 hydroxyl group of Gal  
SNA-I  Sambucus nigra-I 500 Lac Neu5Acα2-6, (Lac core)  
STA Solanus tuberosum 500 GlcNAc 
GlcNAc oligomers 
(LacNAc,or LacdiNAc) 
SJA Sophora japonica 1000 Gal GalNAc 
TKA Trichosanthes kirilowii 500 Gal β-Gal, Neu5Acα2-3/6Galβ1 
WGA Tritiicum vulgare  1000 GlcNAc 
β-GlcNAc, sialic acid, 
GalNAc 
TL Tulipa sp. 1000 GlcNAc 
GlcNAc, Man, biantennary 
complex N-linked glycans 
UEA-I Ulex europaaeus I 500 Fuc Fucα1-2Galβ1-4GlcNAc 
UEA-II Ulex europaaeus II 1000 GlcNAc 
Fucα1-2Galβ1-4Glc(Nac), 
Chitin 
UDA Uritica dioica 1000 GlcNAc 
High Man, GlcNAcb1-
4GlcNAc oligomers 
VGA  Vicia graminea 500 Gal 
O-linked Galβ1-3GalNAc 
clusters 
VVA Vicia villosa 500 Gal GalNAc 
VVA 
(man)  Vicia villosa 500 Gal Man 
VRA  Vigna radiata 500 Gal α and β-Gal  
VFA Vicia fava 500 Gal Man, Glc, GlcNAc 
WFA Wisteria floribunda 500 Gal GalNAc 
RCA B Ricinus communis agglutinin B 1000 Lac 
Terminal β-Gal, terminal 
LacNAc 
HHL Amarylis Lectin 1000 Man Manα1-3 and 1-6 
MAL- I Maackia amurensis  -I 1000 Lac NeuAcα2-3LacNAc 
MAL-II  Maackia amurensis -II 500 Lac NeuAcα2-3LacNAc 
PTL-I Psophocarpus tetragonolobus 1000 Gal 
αGalNAc, Blood A and B, 
Galα1-3GalNAcα  
PTL-II Psophocarpus tetragonolobus 1000 Gal βGalNAc,  Type II Blood H  
CVN  Cyanovirin 1000 Man High Man 
SVN Scytovirin 500 Man High Man 
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GRFT Griffithsin 500 GlcNAc High Man 
Chol Tx  Cholera Toxin 2000 Lac Ganglioside (GM1) 
ACA Amaranthus Caudatus 1000 Man GalNAc, Galβ1-3GlcNAc 
ASA Allium sativa 1000 Man High man (Man9-GlcNAc2) 
MPA Macluria Pomifera 500 Gal Tn and Tα antigens 
PSL Polyporus Squamosus 1000 Lac NeuAcα2-6LacNAc 
TJA-I Trichosanthes japonica 1000 Lac 
NeuAcα2-6LacNAc or 6-
Sulfo LacNAc. 
TJA-II Trichosanthes japonica 500 Lac 
Fucα1-2Galβ1-3/4GlcNAc, 
GalNAcβ1-4Galβ1  
Gal-9 Galectin-9 500 Lac 
GalNacα1-3GalNacβ1-
3Galα1-4Galβ1-4Glc 
AMA Arum maculatum 1000 Man 
Biantennary core (GlcNAc), 
high man, LacNAc 
Calsepa Calystegia sepium 500 Man 
Complex N-linked with 
bisecting GlcNAc 
HAA Helix aspersa  1000 Gal Terminal GalNAc 
MOA Marasmium oreades agglutinin  1000 Gal Galα1,3Gal, Blood B 
IRA lris hybrid 1000 Gal GalNAc 
MNA-G Morus nigra 1000 Gal Tn and Tα antigens 
GafD† Escherichia coli F17 fimbriae 500 GlcNAc β-GlcNAc 
PA-IL† Pseudomonas Aeruginosa Lectin II 500 Gal Terminal α-Gal 
PA-IIL† Pseudomonas Aeruginosa Lectin III 500 Fuc  α-Fuc, high Man 
PapGII† Escherichia Coli Pap Adhesin 500 Gal Globotetraose 
PapGIII† Escherichia Coli Pap Adhesin 500 Gal Globopentaose 
RS-IIL† 
Ralstonia solanacearum Non-
fimbriae 500 Man Man, Fuc 
Table 3.1: Lectin printlist and specificities. Print Buffer: 0.005% Tween in PBS pH 
7.6. † Print Buffer for Oriented Lectins: 100 mM Glutathione in 50 mM 






Chapter 4:  Investigating the role of lectin-glycan interactions in 
microvesicle protein sorting 
4.1 INTRODUCTION 
Overview 
In the previous chapter I demonstrated that microvesicles from diverse sources 
display a common glycomic signature, in contrast to the cell membranes, which had 
significant differences in their glycosylation profiles based on cell type. Since 
glycosylation is a known cellular trafficking signal for proteins, this leads to the 
hypothesis that it may also play a role in sorting glycoproteins to microvesicle bound 
domains. This chapter explores the possibility that lectin-glycan interactions are 
responsible for the conserved microvesicle glycome. 
 
Determinants for microvesicle protein incorporation  
There are many lines of evidence that point to active sorting mechanisms for the 
incorporation of molecular content of microvesicles. For example, microvesicles are 
known to contain distinct sets of proteins (i.e. CD63 and CD81), lipids (cholesterol rich 
lipid rafts in ectosomes) and RNA, implying that the molecular content of microvesicles 
is not simply a random assortment of cellular material. Although some progress has been 
made towards understand this process, the mechanisms that drive microvesicle biogenesis 
are still largely undefined. 
The endosomal sorting complex required for transport (ESCRT) machinery sorts 
ubiquitinated proteins to multivesicular bodies (MVB). Since exosomes are said to 
originate from MVB or MVB-like structures, the ESCRT machinery was thought to be 
important for cargo sorting to exosomes. However, neither ubiquitination nor the ESCRT 
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machinery is required for inclusion of proteins into secreted vesicles [106]. An alternative 
theory is that oligomerization is a key sorting determinant of membrane-bound proteins. 
There is increasing evidence that the formation of membrane-bound highly oligomeric 
protein structures may be a sorting determinant. Evidence for this theory comes from 
several sources. Antibody- and lectin-induced crosslinking of TfR and AChE led to 
increased secretion of these proteins in exosomes from reticulocytes [107]. Additionally, 
Gould et al. determined that highly oligomeric cytosolic proteins could be directed to 
exosomes upon addition of an acyl membrane anchor [108]. In T-cells, the secretion of 
MHC II via exosomes was characterized by association with CD9-containing, detergent-
resistant complexes. Since the oligomeric membrane structures were formed artificially, 
it is still unclear whether these structures lead to microvesicle incorporation under natural 
cellular conditions. At this point, the cellular factors that deliver proteins to 
microdomains or that aid in microvesicle membrane budding are still unclear.  
 
Lectins in protein trafficking 
The modification of proteins with N- and O-linked glycans is a well-known 
marker for trafficking of glycoproteins to different destinations in the cell. This process 
involves the recognition of specific glycans by lectins that sequester and cluster the 
glycoproteins into membrane microdomains. A classic example of this is the sorting and 
trafficking of N-linked glycoproteins that occurs after post-translational processing in the 
ER and Golgi. The removal of properly folded proteins from the ER for entry into the 
Golgi is facilitated by mannose-binding lectins, such as ERGIC-53, VIP36, and VIPL 
[109]. Misfolded proteins are recognized by the lectin EDEM after the removal of one 
mannose residue, and sorted to the ER-associated degradation pathway [110]. In addition, 
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sorting of lysosomal hydrolases from the golgi to the lysosome occurs after the proteins 
are tagged with phosophomannosyl moieties and subsequently recognized by mannose-6-
phosphate receptors (MPR). The receptor-ligand complexes are sequestered into tubular 
structures at the trans-golgi network and eventually packaged into clathrin-coated 
vesicles that are destined for the lysosome [111].  
The proper function of polarized epithelial cells requires the differential transport 
of membrane bound receptors and transporters to either the apical or basolateral domains 
of the cell. Sorting into apical and basolateral bound vesicles is done in the trans-Golgi 
network followed by transport to the appropriate plasma membrane regions. Both N- and 
O-linked glycosylation have been identified as apical sorting signals, whereas basolateral 
sorting signals are confined to the cytoplasmic domain of proteins. This has been 
demonstrated both by addition of glycans to normally non-polarized proteins as well as 
the disruption of apical transport after glycosylation inhibition. Members of the galectin 
family have been implicated in apical sorting of glycoproteins and glycolipids in 
polarized cells [112]. Galectins are a family of 14 β-galactoside-binding mammalian 
lectins that are defined by a homologous carbohydrate recognition domain. They are 
found intracellularly in the nucleus and cytoplasm but they can also be secreted to the 
extracellular space via a non-classical secretion pathway. Multiple proteomic studies 
have identified galectins in microvesicles [11, 92, 113].  
All galectins can form multimers, allowing for crosslinking of glycans and the 
formation of glycoprotein clusters. This multivalency of galectins is an important aspect 
of their cellular function [114]. In Madin-Darby canine kidney cells and mouse intestines, 
the carbohydrate-directed sorting of numerous membrane glycoproteins is aided by 
galectin-3. This multivalent lectin recognizes specific O- and N-linked carbohydrates and 
can form high molecular weight glycoprotein complexes which will then be trafficked to 
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the apical membrane [115, 116]. In the polarized colon cancer cell line, HT-29, binding 
of galectin-4 to sulfated glycosphingolipids leads to incorporation into “superaft” 
membrane domains and apical delivery [117].  
 
4.2 RESULTS AND DISCUSSION 
Direct comparison of microvesicles and cell membranes 
As discussed in chapter 3, we observed a conserved glycan signature, with both 
enrichment and depletion of certain glycans compared to the parent cells. We 
hypothesized that this could be the result of a carbohydrate-based sorting process for 
glycoprotein incorporation into microvesicles. To look more closely at the glycomic 
differences between the parent and microvesicle membranes, I directly compared them on 
the lectin microarray using the dual-color assay. In a direct comparison, competitive 
binding between the microvesicles and the parent membranes clearly designate glycans 
that are differentially expressed on the microvesicle surface. Cy3-labeled microvesicles 
and an equal protein amount of Cy5-labeled membranes were mixed and incubated on the 
lectin array (Figure 4.1A). In this experiment, there was a consistent difference in the 
overall fluorescence intensities between the microvesicle and membrane samples that I 
had not previously encountered. This may be due to uneven dye degradation between the 
Cy3-labeled microvesicles and the Cy5-labeled membranes. This is surprising as Cy3 is 
typically more stable than Cy5, however, their storage in different buffers may account 
for the uneven dye degradation. Membrane preparations are dialyzed in PBS after 
labeling to remove excess dye. Because of the limiting amounts of microvesicles and the 
potential for loss from dialysis, the microvesicles are not dialyzed after labeling. Instead, 
the NHS-Cy3 labeling reaction is quenched by the addition of 200 mM Tris buffered 
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saline (TBS) ph 6.7 bringing the pH to 7.6. Therefore, Cy3 stored in a mixture of 
bicarbonate buffer and TBS may degrade more rapidly over time than Cy5-labeled 
membranes stored in PBS. To account for discrepancies in the intensities of the 
membranes and the microvesicles, the array data were median-centered. Although there 
was no common biological reference, heirarchical clustering using the Pearson 
correlation and average linkage analysis again showed a clear glycopattern (r = 0.66, N = 
72 lectins, P < 0.0001). The previously observed pattern of enrichment (polyLacNAc, 
high mannose, complex N-linked glycans) and depletion (terminal GalNAc, blood group 
A or B antigens) of specific glycans was prominently displayed (Figure 4.1B). This 
implies that the glycan signature is due to an active sorting mechanism for incorporation 
of glycoproteins and/or glycolipids to microvesicles.  
To test for the appropriateness of our global normalization method, I performed 
several lectin blots to compare Sk-Mel-5 microvesicles and membranes. Equal protein 
amounts were separated by gel electrophoresis and probed with TKA, ECA, TJA-I, NPA 
and DSA. Based on the array data, the lectins ECA and TKA (terminal Gal and GalNAc) 
preferentially bind to the membranes, whereas NPA (oligomannose) and TJA-I (α2-6 
sialic acid) preferentially bind to the microvesicles. The ECA and TKA lectin blots 
confirmed the scarcity of their binding epitopes in the microvesicles in accordance with 
the array data (Figure 4.2). The DSA blot shows a clear enrichment of polyLacNAc in the 
microvesicles. However, the TJA-I and NPA blots were more difficult to interpret and 
did not completely correlate with the enrichment seen on the arrays for the microvesicles. 
This is because different sets of bands were more pronounced in both the microvesicles 
and the membranes. For TJA-I, the reason for this may be that the sialic acid signal seen 
in the arrays was in part due to sialylated glycolipids that are abolished after gel 
electrophoresis and therefore not detected by the lectin blot assay. This would not explain 
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the discrepancy in NPA binding, because glycolipids are not known to contain 
oligomannose residues. Because certain lectins only recognize higher ordered polyvalent 
structures, the lectin array may be a more suitable platform to measure these interactions 
than by separation on a gel. Nevertheless, several TJA-I and NPA reactive proteins were 






Figure 4.1: Direct comparison of microvesicles with their parent cell-membranes. (A) 
Experimental schematic. Equal amounts of Cy3-labeled microvesicles (MV) 
were analyzed against Cy5-labeled parent membranes (MB) on the lectin 
microarray.  (B) Arrays were hierarchically clustered using the Pearson 
correlation coefficient as the distance metric and average linkage analysis (R 
= 0.66, N=72 lectins, P < 0.0001, students two tailed t test). Heat map of the 
median-centered data is shown. Red indicates greater binding to MV; green 
indicates greater binding to MB. HCT-15 (HC), SupT1 (S), Jurkat (J), HT29 
(HT), SkMel-5 (Sk). 
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Figure 4.2 Lectin blot comparison of Sk-Mel-5 MB and MV. Equal protein amounts of 
were probed by the lectins TKA, ECA, TJA-I and NPA. Lectin microarray 
data from the direct comparison of MV and MB are shown for comparison. 
A representative ponceau stain from the TKA blot is shown as evidence of 
equal protein loading. 
 
DSA blots identify distinct glycoprotein cohorts 
The conserved glycosylation profiles could be the result of a carbohydrate 
mediated sorting mechanism analogous to those of apical glycoprotein sorting. 
Alternatively, the observed glycome could simply arise from the presence of predominant 
conserved proteins or lipids that contain the same glycoforms but are sorted by 
glycosylation independent mechanisms. For example, it was previously determined 
(Chapter 2) that CD63, a protein commonly associated with exosomes, was present in all 
of the vesicles anlayzed on the array. CD63 is a highly glycosylated protein known to 
contain complex N-linked polyLacNAc glycans [118] and is highly enriched in 
microvesicles when compared to cell membranes (Figure 4.3). Thus, this protein alone 
could potentially account for the enrichment of the polylactosamine component of the 
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microvesicle glycan signature. Using lectin array data alone, we cannot distinguish 
between these two possibilities. Therefore, I performed a lectin blot assay with DSA so 
that individual glycoprotein bands could be visible. The binding epitope of DSA is 
polyLacNAC found in complex N-linked glycans, which is one of the epitopes that is 
enriched in microvesicles. Equal amounts (1.5 µg protein) of microvesicles and 
membranes from three cell lines, SkMel-5, HT-29 and Jurkat, were probed. The 
microvesicles from each cell line showed a distinct pattern of DSA-positive bands. This 
provides preliminary evidence that different glycoproteins are responsible for DSA-
reactivity in microvesicles from distinct cell lines (Figure 4.4A). To confirm enrichment 
of DSA epitopes in the microvesicle, the lectin blot lanes were quantified. The levels of 
enrichment observed in the microvesicles from the three cell lines were correlated with 
the microarray data with Sk-Mel-5 microvesicles displaying the most enrichment and 
Jurkat microvesicles displaying the least (Figure 4.4B).  
 
 
Figure 4.3 Microvesicles are highly enriched in CD63, a glycoprotein known to contain 
N-linked polylactosamine glycans. Equal protein amounts of MV and MB 




Figure 4.4 (A) DSA lectin blot of equal protein amounts of SkMel-5, Jurkat and HCT-
15 MB and MV shows enrichment of DSA epitopes on multiple proteins in 
MV. (B) Lanes were quantified using NIH image by drawing 5 vertical lines 
through each lane and plotting the mean luminescence units for each lane ± 
SD. This was done to avoid bias due to lane imperfections. The level of 
enrichment in DSA binding to the microvesicles correlated with the lectin 
microarray data (shown for DSA). 
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A potential role for galectins in microvesicle-directed protein sorting  
As previously mentioned, several labs have shown that oligomerization is 
sufficient to target membrane bound proteins to microvesicles [107, 108, 119]. Thus, the 
propensity for lectins and glycans to form highly clustered oligomeric complexes through 
their multivalent interactions makes lectins ideal candidates for microvesicle directed 
protein sorting. The presence of polylactosamine as a conserved feature of the 
microvesicle glycome, led us to the hypothesis that galectins may be involved in 
recognition and sorting of microvesicle bound proteins. Many members of the galectin 
family of lectins have an affinity for polyLacNAc epitopes. In addition, proteomic studies 
have identified galectins in microvesicles from various sources including galectin-5 in rat 
reticulocytes, galectin-7 in human parotid glands, galectin-3 in colorectal cancer cells and 
mouse dendritic cells and galectin-4 in HT-29 [92, 113, 120, 121].  
 I tested for the presence of galectins-3 and -4 in our panel of microvesicles by 
Western blot analysis. These lectins are known to be involved in apical trafficking of 
glycoproteins in polarized epithelial cells[112]. Figure 4.5 shows the presence of 
galectin-3 in SkMel-5, HCT-15 and HT-29 microvesicles. Galectin-4 was present in the 
microvesicles of the T-cell line H9 and the colon cancer cell line HT29. Because of the 
limiting amounts of HT-29 microvesicles, the western blot was not repeated to confirm 
the presence of galectin-3 in microvesicles from this cell line. Microvesicles from the T-
cell lines Jurkat and Sup-T1 did not contain visible amounts of either of the two galectins. 
Expression of galectins is cell line dependent, with distinct galectin members 
differentially expressed in different cells. Therefore, it is possible that other galectins are 
present in Jurkat and Sup-T1. The multiple examples of the presence of galectins in 
microvesicles suggest that they play an important role in microvesicle biology. In 
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particular, the presence of galectins-3 and -4, which are known to be mediators of apical 
glyan sorting, implies that these lectins may have an analogous function in microvesicles. 
 
 
Figure 4.5 The panel of cell derived microvesicles were probed for galectin-3 and 
galectin-4 by western blot analysis. The microvesicles that are positive for 
the galectins are shown. 
 
Galectins form intricate complexes called galectin-glycan lattices on the cellular 
surface through their multivalent interactions with cell surface glycoproteins (Figure 4.6). 
By this clustering mechanism, they regulate important cellular events such as apoptosis, 
differentiation and immunity [122, 123]. A common way that researchers disrupt the 
formation of galectin lattices is by inhibiting galectin with lactose. To investigate if 
galectin-glycan interactions are important for microvesicle formation, Sk-Mel-5 cells 
were treated with 100 mM lactose in serum-free media. After 15 h, conditioned media 
was ultracentrifuged for microvesicle isolation and the resulting pellets were probed for 
the presence of the glycoprotein, CD63. Lactose treatment of the cells resulted in a 
drastic reduction in CD63 compared to the microvesicles from the untreated controls 
(Figure 4.7) Even though CD81 is not glycosylated, a similar reduction was also seen 
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after lactose treatment. Both CD81 and CD63 are known to have multiple binding 
partners and recruit proteins to tetraspanin enriched microdomains, sometimes called the 
tetraspanin web [124]. Therefore, recruitment of CD81 to microvesicle may have been 
inhibited after lactose treatment due to its interaction with a glycoprotein.  
Although many more studies are needed to test this, treatment of the cells with a 
high concentration of lactose could potentially be inhibiting important lectin-glycan 
interactions that are needed for incorporation into microvesicles. If this is true, one would 
expect a decrease in protein yield from the conditioned media after lactose treatment. In 
fact, the protein yield from untreated cells was 46 µg and from lactose treated cells was 
30 µg. However, this experiment has not been replicated and therefore it is not yet known 
whether the difference in protein amounts is significant.  
 
 




Figure 4.7 Lactose treatment of Sk-Mel-5 cells causes a decrease in secretion of CD63 
and CD81. Sk-Mel-5 cells were treated with 100 mM lactose or no lactose 
in serum-free media for 15 h. Microvesicles were isolated and 5 µg of 
protein were probed with antibodies to CD63 and CD81. 
 
Transfection of Sk-Mel-5 with galectin-3 shRNA  
Compared to the rest of the cell lines used for our glycomic comparison, Sk-Mel-
5 produced the greatest microvesicle protein yield. In addition, Sk-Mel-5 microvesicles 
contained galectin-3 making this cell line ideal for further analysis. Initial studies suggest 
that CD63 and CD81 incorporation into microvesicles is inhibited by lactose in Sk-Mel-
5. Since galectin-3 is a known mediator of protein trafficking and can be inhibited by 
lactose, we hypothesize that it may be influencing protein trafficking to Sk-Mel-5 
microvesicles. To investigate this, cells were transfected with a plasmid that contains 
galectin-3 shRNA, red fluorescent protein (RFP) as a transfection marker and a 
puromycin resistance marker. Figure 4.8 shows the cells with approximately 50% 
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transfection efficiency. Future work requires the creation and propagation of stable cell 
lines containing the galectin-3 shRNA plasmid for the production of microvesicles.  
Changes in the proteomic content of microvesicles obtained from these cell lines should 
provide insights into the importance of galectin for protein incorporation. 
 
 
 Figure 4.8 Transfection of Sk-Mel-5 cells with galectin-3 shRNA plasmid. Cells were 




By comparing lipidomic, proteomic and transcriptomic microvesicle studies, 
researchers hypothesize that incorporation of microvesicle content is not a random 
process, but rather, incorporation occurs through an active sorting mechanism [4]. My 
work adds more evidence to this hypothesis through the identification of a conserved 
microvesicle glycome that is defined by both the enrichment and exclusion of cell 
membrane glycans. This glycan signature could be the result of a conserved set of 
microvesicle glycoproteins. However, by lectin blot analysis I observed distinct sets of 
protein bands in microvesicles from three different cell lines. This suggests that the 
conserved signature is more likely due to a glycan sorting mechanism, resulting in the 
enrichment of polylactosamine, high mannose, and complex N-linked glycan-containing 
proteins in microvesicles. Galectins are candidates for recognition and sorting of proteins 
that contain polylactosamine. Galectins-3 and -4 are known protein trafficking agents that 
were observed in several of our microvesicles. After cells were incubated in the presence 
of lactose for 20 hours, there was a considerable decrease in secretion of exosomal 
markers. This is further evidence that galectins may involved in microvesicle protein 
incorporation. 
Pioneering work from the Gould lab has demonstrated by several exogenous 
means that the crosslinking of proteins at the cellular membrane can lead to an increase in 
microvesicle incorporation [108, 119]. My work puts forth compelling evidence for our 
hypothesis that galectins may be one of the responsible crosslinking agents that target 
microvesicle incorporation in vivo. Formation of a galectin lattice on the cellular surface 
may be a precursor to membrane budding. The work of Linda Baum and several other 
labs indicates that association with galectin lattices retains glycoproteins at the cellular 
surface by preventing endocytosis [122]. For example, galectin-9 lattices serve to retain 
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glucose transporters at the cellular surface and the absence of galectin-9 leads to diabetes 
in mice models [125]. In addition, galectin-3 lattices can inhibit the endocytosis of 
cytokine receptors leading to retention of tumor growth factor-β receptor on the surface 
of tumor cells [126]. 
If the same is true for Sk-Mel-5, this would have implications for the biogenesis 
of microvesicles in these cells. Endocytosis is said to be the process by which proteins are 
sorted through to the endosome and eventually to exosomes. Since secretion of CD63 and 
CD81 is decreased upon lactose treatment, presumably disrupting the formation of 
galectin lattices and increasing exocytosis, this would suggest that tetraspanin-containing 
vesicles are budding directly from the cell surface. Although this is not thought of as the 
typical biogenesis pathway for tetraspanin containing vesicles, outward microvesicle 
budding of CD63-enriched domains has been previously observed at the cellular surface 
[27].  
   
4.4 MATERIALS AND METHODS 
Direct comparison of microvesicles and cell membranes on the lectin microarray 
Labeled samples used for direct comparison of microvesicles and parent cell 
membranes were procured previously from serum free conditioned media. Details of the 
cell culture conditions, isolation of microvesicles, membrane preparations, dye labeling 
and lectin microarray protocols are described in chapter 2. 
Equal amounts (1.5 µg) of Cy3-labeled microvesicles were incubated with equal 
amounts of Cy5-labeled parent cell membranes in 100 µl total volume PBST. Samples 
were hybridized to the lectin microarrays for 2 h at room temperature with gentle 
rocking. The individual subarrays were then washed with PBST for 5 x 5 min with a final 
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10 min wash in PBS. Slides were scanned and analyzed using a GenePix 4300B 
fluorescent slide scanner (Molecular Devices, Sunnyvale, CA) with GenePix Pro 7 
software at a resolution of 5 µm. The photomultiplier (PMT) gain settings were 500 for 
the Cy3 channel and 450 for the Cy5 channel. For each channel, the background 
subtracted median fluorescence of the three replicate spots per lectin was tested for 
outliers using the Grubbs outlier test with alpha = 0.05. The log2 values of the average 
fluorescence of the 3 replicate spots were median centered over the array in each channel 
to account for differences in labeling efficiency. The resultant datasets (arrays and 
lectins) were hierarchically clustered by the log2 ratios using the Pearson correlation 
coefficient with average linkage analysis (Cluster 3.0). Clusters were visualized with Java 
Treeview.  Arrays were considered to be statistically similar if P < 0.0001. P values were 
obtained by employing a two tailed t test (N = number of lectins, r = Pearson correlation 
coefficient, Df = N-2,) using the online statistical calculator: 
http://faculty.vassar.edu/lowry/tabs.html#r.  
 
Lectin blots  
Microvesicles and membranes were procured previously from serum free 
conditioned media. Details of the cell culture conditions, isolation of microvesicles and 
membrane preparation protocols are described in chapter 2. Proteins (10 µg) were 
separated by SDS-PAGE (precast 4-20% polyacrylamide gel, Thermo Scientific) and 
transferred to nitrocelluse. Biotin-conjugated lectins (EY Laboratories, San Mateo, CA) 
were diluted in 5% bovine serum albumin (BSA) in PBST (phosphate buffered saline 
with 0.05% tween) to a final concentration of 1 µg/ml. Membranes were incubated with 
the lectins for 1 hour at room temperature. After washing in PBST, lectins were incubated 
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with streptavidin-HRP (Jackson ImmunoResearch, West Grove, PA) diluted 1:500 in 5% 
BSA/PBST. Blots were visualized using Supersignal West Pico Chemiluminescent 
Substrate (Thermo Scientific) on a G:Box gel imaging system (Syngene). 
 
Western blots 
Microvesicle and cell membrane proteins (3 µg of protein) were separated by 
SDS-PAGE under non-reducing conditions and transferred to nitrocellulose membrane. 
Samples were probed with antibodies to CD63 (1:500 dilution) (RFAC4, Millipore, 
Billerica, MA) and CD81 (1: 500 dilution) (H-121, Santa Cruz Biotechnology, Santa 
Cruz, CA), followed by incubation with the appropriate HRP-conjugated secondary 
antibody (1:10,000 dilution) (Bio-Rad, Hercules, CA). Blots were visualized using 
Supersignal West Pico or Supersignal West Femto Chemiluminescent Substrate (Thermo 
Scientific) on a G:Box gel imaging system (Syngene). 
 
Lactose treatment of Sk-Mel-5 cells 
Sk-Mel-5 cells were cultured in normal growth media (RPMI with 10% fetal 
bovine serum and 2 mM L-glutamine) in 10, 15 cm dishes until cells reached 80% 
confluency. Cells were gently rinsed twice with 5 mL serum-free media before addition 
of serum-free media with 100 mM D-lactose or serum-free media alone. Conditioned 
media was obtained 20 h post treatment and microvesicle isolation protocol was followed 
as previously described in chapter 2. 
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Transfection of Sk-Mel-5 cells with galectin-3 shRNA 
The galectin-3 shRNA vector (pRFP-C-RS) was obtained from Origene 
Technologies and the Transit 2020 transfection reagent was from MirusBio. Sk-Mel-5 
cells were cultured in 6 well dishes and transfection was done according to the 




Chapter 5:  Conclusions 
The original goal of my research was to examine the glycosylation profiles of 
microvesicles. These cell-membrane derived extracellular vesicles can interact with other 
cells and are a vehicle for intercellular communication and transport. Glycosylation is 
often the first point of contact between a cell and its environment. Because of this, 
glycosylation plays a crucial role in numerous extracellular events including receptor 
activation, circulation half-life, homing to specific tissues and cell-cell recognition. 
Therefore, determining the glycomic content of microvesicles would provide important 
insights into their function and modes of cellular interaction. I chose to study 
microvesicles from multiple diverse sources so that I could compare their glycomes. This 
included microvesicles derived from human T-cell, colon and skin cancer as well as 
human breast milk from a healthy donor. Despite this diversity, a conserved glycomic 
signature for microvesicles was observed. Based on this data, the use of glycosylation as 
a marker for differentiating microvesicles from normal and healthy cells may not be 
possible. This has important implications for the utilization of glycans as markers in 
microvesicle diagnostics. On the other hand, the conserved glycome could potentially 
lead to glycan-based microvesicle isolation methods from biological fluids and cell 
culture media. 
The identification of a conserved glycome defined by the enrichment and 
exclusion of certain glycan epitopes led us to hypothesize that glycosylation could 
potentially be a signal for sorting of glycoproteins and glycolipids to microvesicles. The 
second aim of my project was to investigate if lectin-carbohydrate interactions played a 
role in microvesicle-directed sorting of proteins. To this end, I identified galectin-3 and 
galectin-4, known glycoprotein trafficking agents, in several of the microvesicle samples. 
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These galectins are known to recognize polylactosamine, an epitope that was highly 
enriched in the microvesicles. This work therefore serves to identify galectins as 
candidates for microvesicle trafficking agents. Although further work is needed, initial 
data suggests that inhibition of galectin-3 lattices may interfere with protein incorporation 
into microvesicles. Future work would require a closer examination of the role of 
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